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i. ABBREVIATIONS: 
All chemical symbols have their usual meanings. 
ATP adenosine triphosphate 
CoA coenzyme A 
CoASH free coenzyme A 
HADPH2 reduced nicotinamide-adenine dinucleotide phosphate 
NADH 2 reduced nicotinamide-adenine dinucleotide 
NADP nicotinamide-adenine dinucleotide phosphate- 
Tris Tris (hydroxymethyl) methylamine 
EDTA ethanolaminediariinetetraacetic acid 
TCA trichloracetic acid 
DNA deoxyribosenucleic acid 
Ci Curie 
nm nanometer 
molar 
Tril millimolar 
jil'i microniolar 
mol m0l e, 
nmol nanomole 
1 
SUMMARY 
The study of b iochemical aspects ol brain riietabolisi-, i is very ccn-Plex 
because brain tissue is composed of different cell types. The two 
major cell types are neurones and Olia .'- -- 
'- These two cell 
types have differing roles but are very closely associ a te dwi th 
norm. al, brain development and function. oligodendrogii a are respgns'lble 
for the synthesis and maintenance of the riyelin mem5rane. in the 
developing brain, the myelin mem. brane is formed during a very sýoft 
period of time. 
The aims of this study are (i) to investigate age-dependent chanrjes 
in the activity of the lipogenic enzymes, fatty acid synthetase and 
palmitoyl-CoA synthetase uhich are intimately involved in the synthesis 
and activation of fatty acids for the formation of phospholipids for 
incorporation into the myelin meinbrane; (ii) to deterriiine the. sub- 
cellular location of these enzynies; (iii) to investigate the effect 
of thyroid hormone on the activity of these enzyr,,, es and (iv) to 
determine the route of fatty acid incorporation into myelin lipids. 
The results presented indicate (i) that the activities of ialuq acid 
synthetase and palmitoyl-CoA synthetase increase during the period of 
myelination; (ii) fatty acid synthetase is found predoninantly in the 
cytoplasmic fraction from brain homogenates, whereas palmitoyi-CoA 
synthetase activity is present in all menribrane fractions, although 
activity measured in myelin ray be due to contamination; (iii) the 
administration of thyroid hormone has no effect on palmitoyl-CoA, 
synthetase, whereas its specific antagonist, propylthiouracil, causes 
a decrease in enzyme activity in the mitochondria-enriched fraction; 
(iv) the accumulation of radioactivity in the myelin fraction from 
labelled fatty.: acid involves all subcellular organelles inciuding 
the cytoplasm and no precursor-product relationship is apparent. The 
results will be considered in the light of data available for lipo- 
genic and other enzymes involved in lipid synthesis. 
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I UTPO DUCT I O', N: 
In this study, the activities of two lipogenic enzymes will 
be considered. One, fatty acid synthetase, is found in 
the cytoplasmic compartment of the cell, while the other, 
palmitoyl-CoA synthetase, is membrane bound. In order to 
understand their separate and sequential roles in the synthesis 
and turnover of brain lipids, it is important to consider 
firstly the gross morphological and chemical changes that take 
place in the brain during development and secondly the changes 
in composition and enzyme content of the various subcellular 
fractions. 
The oligodendroglial cells are responsible for the formation 
and maintenance of the myelin sheath around the nerve axon and 
in the following introduction the synthesis and turnover ol. 
myelin lipids will be considered. 
The results of both in vitro and in vivo investigations will be 
discussed in order to illuminate the key roles which the two 
above enzymes must play. The effect of diet and hormones will 
also be considered since both of these are central in the 
formation of. a normal functional brain. However, no attempt 
will be madeý.. to discuss either the accumulation of protein 
during development or the role of neurotransmitters since these 
topics are beyond the scope of this thesis. 
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1.1 MORPHOLOGICAL CHANGES IN THE WHOLE BRAIN 
Growth and development of the brain occurs in two phases (1,2). 
The initial phase, which occurs in the rat and rabbit during late 
p regnancy and between 15 and 20 weeks gestation in man, is 
characterised by neuronal multiplication. The second phase is 
generally referred to as the "brain growth spurt". This period 
lasts about three weeks in the rat, beginning at birth. In man 
it occupies the period from 25 weeks gestation until the third or 
fourth postnatal year. The,, rabbit undergoes its "brain growth 
spurt" from about ten days prior to birth to about thirty days 
aften, iards. Figure 1.1 shot-is the velocity curves for brain growth 
in various species in relation to birth (1). The first half of 
this growth spurt is associated with the proliferation of glial 
cells and the second half with myelin synthesis, which is 
considered to be most active between 5) and 20 days after birth in 
the rabbit. This interval has been called the "period of active 
myelination" or simply "myelination". 
During- this period, the weight of the brain increases rapidly and 
a number of other development processes including myelination, 
proceed at a very high velocity. This period has been identified 
as a period of vulnerability where it is only necessary to retard 
growth to causeý distortions of pattern as well as quantitative 
deficits which are detectable in the adult brain. 
The timing of the "brain growth spurt" in relation to birth makes 
it possible to divide animals into "prenatal", "perinatal" and 
"postnatal" brain developers (3). It was shown by Harel et al 
4 
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FIGURE 1.1 
Velocity curves for brain growth in various species. 
G. hanges in weight as % adult value against time. 
Arbitrary values for age are given and the time periods 
are shown in the key. Taken from refs. 3 and 4. 
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(4) that the rabbit is a "perinatal" developer undergoing its 
period of fastest growth during the birth period. Other 
species whose "brain growth spurt" occurs during the perinatal 
period are the dog, pig, and human (3). The guinea-pig (5) 
and the rhesus monkey (3) are examples of animals which show 
prenatal brain development, while the rat and mouse show post- 
natal brain development. The use of the rabbit as an experi- 
mental animal offers a convenient means of studying factors, 
involved in brain development during birth and early life, which 
may be directly applicable to human brain growth. 
In common with other mammals the "brain growth spurt" in the 
rabbit precedes that for body growth. The brain/body weight 
ratio has its peak prior to birth when the brain is immature and 
has a relatively faster rate of growth than the body. (4) Figure 1.2 
shows the rate of weight increase of the brain and the body 
together with the velocity curves for three distinct regions of 
the brain. The cerebrum shows the earliest peak velocity at 
five days of age. The brain stem shows its peak velocity 
, around ten days of age but this is much lower than either that of 
the cerebrum or cerebellum. The peak velocity of weight increase 
in the cerebellum occurs at fifteen days and is only very slightly 
lower than tha*týof the cerebrum. 
During the last third of the gestational period of the rabbit, the 
primitive cerebral cortex increases in size 100 times and continues 
to increase rapidly after birth, as myelination proceeds. 
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FTPIRF 1.2 
Groý, Ith curves for different regions of the rabbit brain. 
Changes in weight ': as. clo adult value against age in days. 
The different regions examined are shown in the key. 
Taken from ref. 4. 
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Myelin Formation: 
From electron microscope studies it has been shot-in that myelin 
is formed around nerve axons by processes derived from 
oligodendroglial cells in the central nervous system and Schwann 
I cells 
in the peripheral nervous system. Figurel. 3is a diagrammatic 
representation of the oligodendroglial cell cytoplasmic membrane 
progressively forming the multilamellae sheath around the axon. 
As the number of windings increases so compaction takes place 
and the myelin spiral takes on the appearance of mature myelin. 
In the central nervous system a single oligodendroglial cell may 
pI rovide processes for the sheaths of more than one adjacent axon, 
whereas in peripheral nervous tissue more than one Schwann cell 
may be required to form, the sheath between two nodes, and the 
thickness of the membrane varies along the length-of the axon. 
Figurel. 4 represents a transverse section of the myelinated axon, 
the upper part represents a nodal region in the central nervous 
system. In the peripheral nervous system the Schwann cell 
provides both the inner and outer collar of cytoplasm around 
the compact myelin. The outer collar is extended into the 
nodal region as a series of interdigitating processes. Te rmi n- 
ating loops of. compact myelin come into close contact with tHe 
axolemma in the-'region of the node apparently providing some 
barrier for movement of materials into or out of periaxonal 
space. The Schwann cell is covered with a basement membrane. 
In the central nervous system the myelin ends in terminal loops 
near to tile node and there are periodic thickenings of the 
axolemma where the glial membrane is applied in the paranodal 
region. These may serve as diffusion barriers and thus confine 
the material in the periaxonal space. 
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PTNIPP 11 
The progressive envelopment of a nerve axon by glial cell 
processes to form myelin. 
Stages 1 and 2: the gradual envelopment of the axon by 
the glial cell. 
Stage 3: formation of loose myelin 
Stage 4: compaction. Taken from ref. 4. 
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FIGURE 1.4 
Comparison of the nodal region of axons in the central nervous 
system (CIIS) and peripheral nervous system, (PHS). 
ECS: extracellular space. 
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At many nodes in the central nervous system there is considerable 
extracellular space (6). 
If the myelin membrane is unwound hypothetically, as in figure 1.5, 
there is a continuous circuit of cytoplasm around the periphery of 
the membrane and also through the centre that is connected directly 
to the oligodendroglial cell body. It is possible that lipid and 
protein moieties are transported though the channels of oligodendrog- 
lial cell cytoplasm (shown in figure 1.5) and membrane comPoRents are 
replaced in this way (7). 
The amount of myelin surrounding an axon can be correlated with the 
rate of conduction of an action potential in the developing chick 
sciatic nerve (8,9) although the unmyelinated axons are not without 
electrical activity. The intimate relationship between myelin 
and nerve conduction velocity has also been demonstrated in 
experimentally induced focal demyelination (10). 
Since K+ and Na + ions do not move across the ensheathed part of 
the axonal membrane, the myelin sheath allows increased conduction 
velocity along the axon by making the local bielectric current 
generated at a node of Ranvier, act ahead at the next'node and. so 
provide a limited access for current flow. Bunge (6) described 
the myelinated axon as the "super highway" of the nervous system. 
This high velocity phenomenon is that of the sheath as a whole and 
must depend on the characteristics of the axolemma as well as the 
structural morphology-and chemical composition of the myelin 
surrounding it. 
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FTr, IJPF 1 1; 
Hypothetical structure of the unwound myelin sheath. 
This figure is a diagraýatic representation of one of the 
several areas of myelin sheath from a single glial cell 
unwound to show the loops of cytoplasm that are present. 
_c 4ý 
rö 
Z) 
c: 
cö 
%4-- 
0 
U 
J 
(I) 
U 
0 
> 
1: 
LO 
LL 
E U) 
cu 
CL 
0 
il-5 
51 
-C 
as 
C 
. 4-J 
C 
0 
0 
£2. 
0. 
0 
0 
ctS C 
g 
tz. 
0 
1.1.2 Myelin membrane stability: 
be 
14yelin stability, in part, maycaused by: the lipid of the membranes 
which make up the sheath. The amount of lipid found in different 
types of membrane varies greatly. f4yelin has the highest 
lipid content (80% dry weight) erythrocytes anintermediate 
content (40 - 50%) and mitochondria tile lowest (28%) Of 
the lipid molecules in myelin, cholesterol and sphingolipids comprise 
66% of the total. These tvio lipid-classes account for less than 
20% of the total mitochondrial membrane lipid, the rest being made 
up by glycerophosphatides. 
The fatty acid composition of myelin may also contribute to its 
stabi 1i ty. The myelin membrane is particularly rich in saturated 
medium and long chain fatty acids, 70% and 25% respectively, but 
low in polyunsaturated fatty acids (5%) (11 ). By comparison, the 
erythrocyte mmbrane is-rich in medium chain length (65%) and poly- 
unsaturated (3010') fatty acids, whereas rat liver mitochondrial 
membrane lipids contain 60% polyunsaturated fatty acids (11). 
The effect of the increased amount of polyunsaturated fatty acid is 
to increase membrane permeability and decrease its stability. 
O'Brien (12)postulated that the stability of myelin membranes was 
caused-by*the interaction of the non-polar fatty acid chains of the 
lipid moeities in the bilayer. The central region in each 
membrane is only lightly stained with osmium tetroxidein electron 
microscope studies, indicating an area 51 angstroms wide which is 
hydrophobic in nature. 
9 
There is only room for two lipid molecules packed tail-to-tail 
in this region, since the average length of lipid molecules, 
from phosphate group to hydrocarbon tail, is 26 - 28 angstrons. 
Using the models of Vandenheuval, O'Brien suggested that the 
lipid molecules in myelin are more tightly packed together than 
in other membranes and the high degree of stability is due to the 
presence of fatty acids with greater chain lengths than those 
found in other membranes (12). 
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1.2 CHQGES IN THE LIPID COMPOSITION OF WHOLE BMIN 
Large amountsof biochemical data has been accumulated concerning 
the growth and development of the central nervous system in many 
species: pig (13)guinea-pig (5,14) rat (3,15,16,1ý , dog (3), and 
chick embryo (18), with less inf&mation existing about humans 
(3,15,19,20,21). The development of the central nervous system. 
in the rabbit has not been investigated as thoroughly as in the 
maturation have been reported ( 22,23 3 24). During the development 
of the central nervous system there is a progressive accumiulation 
of a relatively large amount of lipid compared with other tissues 
(25,26). Cholesterol and sphingolipids have been shown to be the 
major constituents of total cerebral lipids and these are present 
mainly in the isolated myelin membrane. 
rat and other species, although lipid and protein changes during 
In the develoPing rabbit brain there is a continuous increase in 
both wet and dry weight up to adult age (Fig. 1.6)(24). Lipid is 
deposited up to adult age but accumulates maximally between 3 and 
20 days. Although the amount of protein (mig/brain) increases 
thoughout development, it accounts for a decreasing proportion of 
the dry weight, of the brain (64% in the neonate to 44% in the 
mature brain). The 3-fold increase in DNA during development, 
in fact, represents a sharp decrease on a dry weight basis and 
may reflect major increases in cell size during this period (24). 
The highest rate of accumulation of lipid corresponds with the, 
most active period of myelination. 
11 
17Tr-IIDF7 I r, 
Relative changes in composition of rabbit brain during 
development. 
Changes in i-,, et weight, DAA, protein and lipid content 
are plotted against age in days. The values prior to 
birth are days gestation. Drawn from values presented 
in ref. 24. 
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Table la (59) shows that increasing amounts of various lipids are 
deposited in the brain during development. There is a striking 
increase in cholesterol content of rat brain during the period 
between 3 and 20 days post partum, and a much more marked 
accumulation of phospholipids occur during the same time. Dalal 
and Einstein (22) showed a large increase in the cholesterol 
content of the developing rabbit brain, and a similar change in 
the cholesterol, cerebroside and sulphatide can be seen in the 
results of Radin (28) for whole rat brain. The appearance of 
cerebroside is delayed in the rat brain and at 20 days of age its 
rate of deposition is comparable with that of the other lipids 
(27). Similar results are seen in the developing rabbit 
brain (see table 1.1b)(24). 
In the developing rat brain, dramatic increases in certain 
phospholipids are seen. ' Figurel. 7shovis the levels oi different 
phospholipids (pmol/brain) in the rat brain expressed as a 
percentage of the adult value. 
Both ethanolamine plasmalogen and triphosphoinositide are important 
components of myelin, although they are found in other membranes 
and they show a larger increase during the period of most active 
myelin deposition-than phosphatidylethanolamine and phosphatidyl- 
choline which are more general components of cell membranes. 
Sphingomyelin is also closely associated with myelination. 
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TABLE I. la 
Lipid composition of the developing rat brain. 
The values shown are % adult value (jimol/brain) 
for total lipid, cholesterol, cerebroside and total phospholipid 
at each age in days. Taken from ref. 27. 
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FIGIIPF 1-7 
The levels of some phospholipids in the developing rat brain shot-in 
as % adult value (limol/brain ). against age in days. 
The phospholipids shown are: phosphatidylcholine, 
-- phosphatidylethanolamine, +- ethanolamine 
plasmalogen, sphingonyelin and triphospho- 
inositide. Taken from ref. 27. 
Fýurel. 7 The levels of some phospholipids in rat brain. 
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If the concentration of phospholipid (mmol /1100gm fresh Iti ssu. e) 
from rat brain is plotted against loglo of the age, as suggested 
by Rouser and Yamamoto (29), an increase in concentration occurs 
up to 100 days, since this form of data expression condenses the 
time scale. The increase in phospholipid concentration ( mmol) 
and concomitant increase in the size of the rat brain during maturity 
probably indicates that myelin formation continues well into adult 
Ii fe. 
During the rapid accumulation of lipid in the myelinating brain, 
the composition of the phospholipid fraction varies. Table 1.2a. (24) 
shows the phospholipid composition of the developing rabbit brain. 
Phosphatidylethanolamine and sphingomyelin account for an increasing 
proportion - 
proportion 
- of the phospholipid while the ,. 
of phosphatidylcholine 
fall. s. Phosphatidylserine, phosphatidylinositol and phosphatidic 
proportion 
acid show only a slight decrease in with age. In the rat 
rnproportion brain (Table 1.2b)(27) 0- of phosphatidylserine and phosphatidyl-- 
inositol does not fall as in the rabbit brain, but phosphatidyl- 
ethanolamine and sphingorr-yelin increase while phosphatidylcholine 
decreases inproportion. The differences in the trends shown by each 
animal may be due to differences betý, -jeen the species. In addition 
to changes in the relative proportions of each phospholipid, an 
alteration in thýefatty acid composition of the phospholipids also 
occurs. In theýdeveloping ratbrainthe proportion of C18: 0 and 
C 18: 1 fatty acids in phospatidy1choline 
increases at the expense of 
C 16: 0 and C 16: 1 (30) and this 
is probably true for most glycero- 
phosphatides (31). 
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TABLE 1.2a 
Phospholipid composition of the developing rabbit brain. 
The 
" 
amount of each phospholipid present at each age is expressed as 
% total phospholipid at that age. Taken from ref. 24. 
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TABLE 1.2b 
Phospholipid composition of the developing rat brain. 
The amount of each phosoholipid present at each age is expressed as 
% total phospholipid at that age. Taken from ref. 27. 
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The increase in C18: 0 and C 18: 1 is due to the high level of 
these t, io fatty acids in phosphatidylcholine in myelin which 
makes an increasing contribution to the total phosphatidy1choline 
of the brain with increasing age (32). Changes in fatty acid 
composition of the developing rabbit brain are also seen (24). 
Rabbit brain phosphatidy1choline shows a decrease in the amount 
of C16: 1 and C18: 0 and an increase in longer chainlength mono- 
unsaturated fatty acids especially C 18: 1' 
The fatty acid pattern of-sphingomyelin varies only slightly during 
maturation. The predominant species are C 18: 0 and C24: 1 and an 
increasing proporation of very long-chain fatty acids are 
esterified at the expense of the medium chainlength fatty acids. 
Cerebrosides also show similar changes (24). 
Dhopeshwarker (33) also noted a decrease in the palmitate/stearate 
ratio and a corresponding rise in the oleate/stearate ratio in 
older rat brains. In the human brain, similar changes in the 
fatty acid composition have also been shown (34,35). 
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1.3 THE PREPARATION OF SUBCELLULAR FRACTIONS FROM BRAIN TISSUES 
In order to resolve the problems of relating the gross changes in 
the lipid composition of the brain to structure and enzyr,,, e content 
it has been necessary to characterise the chemical composition and 
enzyme content of the sub-cellular organelles. 
The first systematic use of sedimentation characteristics in a 
gravitation. al field to separate subcellular fractions was in 1934 
when Bensley and Hoerr (36) isolated mitochondria. But subce'llular 
fractionation techniques were not applied to brain tissue until 1952. 
Electron microscopic examination of the mitochondrial fraction of 
I brain tissue, revealed the exist nce of sealed off nerve endings 
in this preparation (37,38). These were separated by density 
gradient centrifugation and named synaptosomes (39). The early 
work of Whittaker et al (39,40) and De Robertis et al (41) has been 
developed (42,43) to improve tile separation of subcellular organelles 
from different parts of the nervous system. Methods have also been 
developed for specific nervous. tissue components such as microtubules, 
myelin fragments and postsynaptic membranes, as well as for i-solation 
of nuclei, mitochondria and lysosomes. 
The methodsof tissue disruption are more important when fractionating 
nervous tissue than when disrUpting other tissues. The "formati or, 
of synaptosomes depends upon the method of tissue disruption used. 
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Synaptosomes are lormed when weak shear forces are used, such as in 
a teflon-glass homogeniser. More severe methods of homogenisation 
can be used when synaptosomes are not being investigated, but the 
more violent the techniques used, the greater the tissue disruption 
and the potential loss of other organelles and ultrasonication causes 
the formation of small non-specific membrane vesicles (44). 
Differential centrifugation of nervous tissue is based on schemes 
originally 'devised for the liver, but it yields fractions that are 
far more heterogenous because nervous tissue is composed of a 
variety of cell types and membrane structures. formed from cell processes. 
Further purification of each fraction has been achieved by both 
manipul ating the centrifugation conditions, to cause enrichment of 
a particular organelle, and by density gradient centrifugation. 
By the latter method, subcellular particles are separated according 
to their bouyant density (see Table 1.3). Sucrose gradients are 
most frequently used, although caesium chloride (45) and Ficoll 
(a high molecular weight dextran with low osmotic effect) gradients 
have also been used (46 -50). Subcellular fractions are 
characterised by a variety of criteria. These are : 
(i) Marker enzyme content 
(ii) Protein and lipid composition. 
(iii) An even homogeneous field when viewed under the electron 
microscope. 
When all subcellular fractions of a particular tissue are required 
it is usual to sacrifice absolute purity and use methods which 
yield each fraction. 
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TABLE 1.3 
The size and bouyant densities of many subcellular particles from 
brain tissue. 
For each organelle its size range invand tile molarity of sucrose 
having the same density are given. Taken from ref. 49 . 
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1.3.1 Preparation of Myelin: 
Most methods of myelin preparation rely bn týio properties of the 
myelin membrane, (i) the large vesicle size, and (ii) the lo, a 
density. Homogenisation of brain tissue in sucrose solution, - 
causes the myelin to swell and peel off the axons and reform, in 
spherical vesicles which are in the size range of nuclei and 
mitochondria, and therefore sediment with these tio fractions during 
differential centrifugation. 11yelin also forms multilamella 
structures which will form single membrane vesicles after a 
hypotonic shock. r1yelin vesicles have the lowest density because 
of their high lipid to protein ratio and so density gradient 
procedures were developed to separate myelin from nuclei, mito- 
chondria and synaptosomes. Methods used for the preparation of 
pure myelin fall into two groups, depending on whether they are 
designed to. isolate myelin solely or v. 1hether myelin is obtained 
as only one fraction in a preparation scheme designed to isolate 
all brain subfractions. Although the former methods may give 
rise to a low yield and a sample of nyelin that is not representative 
of myelin in vivo, and the latter methods might give a sample that is 
of lower purity it has been shown that the composition of myelin 
prepared by these methods is not significantly different (51). 
1.3.2 The Enzyme content of INlyelin: 
The criteria for myelin purity are complex since it has little 
enzyme activi V although some lipid synthetic enzymes could be 
expected. 
17 
Under an electron microscope it should give a uniform field of 
large vesicles but there are then difficulties in identifying 
any small vesicles that may be present. Purified nLyelin is 90"1 
soluble in chloroform: methanol (2: 1 v/v). It should. be free from 
the plasma membrane enzymes acetylcholine esterase (EC 3.1.1.7) 
and 5'-nucleotidase (EC3.1.3.5. ); These ti-io enzymes have been 
1.3.3. 
frequently reported in myelin preparations. There should be 
minimal levels of Ila + /K+ ATPase (EC3.6.1.3) succinic dehydrogenase 
(EC 1.3.99.1) from mitochondria, and microsomal NADPH cytochrome 
c reductase (EC 1.6.2.4 )and nucleic acids from endoplasmic 
reticulum and cell nuclei. Purified myelin is associated with 
21 , 3'-cyclic nucleotide-3-phosphohydrolase (52) although it has 
no apparent metabolic function because of its high Km for the 
substrate. The enzyme may be associated with either the axolemma 
or myelin as it is not possible to separate them. The absence of 
measurable activity of the enzyme in the unmyelinated brain and its 
presence in the plasma membrane of glial cells, suggests that 2' , 
3'-cyclic nucleotide-3-phosphohydrolase is associated with myelin. 
Two other enzymes have also been ascribed to myelin (i) leucine 
amino peptidase ( 53 ) (ii) cholesterol ester hydrolase (54 ). 
The Protein Content of Myelin: 
The electrophoretic pattern of myelin proteins isolated from, the 
central nervous, -, tystem is simple compared with other merribrane fractions 
(55). There are tqo major proteins, the proteolipid protein and the 
basic protein, which are not found in the neuronal axolem; m, and also 
a fraction called the "Wolf9ram Protein" which may be heterongeneous. 
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Tile high degree of solubility of myelin in ch 1 oroform: methanol 
(2: 1 v/v) is to a large extent accounted for by the presence 
of the proteolipid protein complex which is soluble in lipid 
solvents and accounts for 60% of tile proteins in myelin (56). 
The proteolipid protein is poor in acidic and basic amino acids and 
rich in the less polar amino acids. This cou ld explain its 
association with lipid and the solubility of the complex in 
lipid solvents. It may have a structural function since 
proteolipid proteins isolated from the myelin of peripheral 
nerves and other membranes have a similar amino acid composition 
(57). 
The basic protein has been extensively studied since it exhibits 
encephalitogenic activity. Bovine brain contains 10 mg. basic 
protein/g wet weight (58). and it accounts for 30% of protein 
in human jqhite matter. It is of interest because it produces 
all, ergic encephalomyelitis when injected into experimental animals. 
It is highly basic and exists as an extended polypeptide chain with 
an isoelectric point greater than 12. The bovine brain species 
has a molecular weight of 18,000. Palmer and Dawson (59,60) 
found that basic protein could form a complex with triphosphoinositide 
of 0.145Vmol TPI/mg protein which %.., as comparable with the ratio 
of TPI to basic protein in the brain. 
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i. 
1.4.1 
CHANGES IN THE LIPID COMPOSITION OF IIYELIN AND OTHER SUBCELLULAR 
FRACTIONS. 
Changes in the lipid composition of myelin: 
týyelin accounts for 50cP of the dry weight of bovine brain white 
matter and 65% of the total lipid. Lipid accounts for 70% 
of the dry weight of myelin from both the central nervous system 
and the peripheral nervous system (61). 14yelin from the 
peripheral nervous tissue contains a higher proportion of sphingo- 
myelin and a lower concentration of cerebroside than myelin from 
the central nervous system. Triphosphoinositide was thought to 
have been exclusive to myelin (62) though more recent work by 
Hawthorne indicates the presence of a small non-myelin pool (r)3). 
In 1965 Horrocks (64) reported that the composition of mouse brain 
myelin changes during development and later it was shown by several 
investigators that the relative proportions of galactolipids, 
cholesterol and ethanolamine plasmalogens increase and the relative 
proportions of choline phosphoglycerides decreases during maturation 
in the mouse brain (165), the rat (27,66-68), the rabbit (22) and in 
man (55,69). In the rat and mouse the increase in the relative 
proportions of galactolipids and cholesterol are nearly equal on a 
molar basis to the decrease in phospholipid (70). 
Cuzner and Davi, Son (27,67) described an even more pronounced increase 
in these lipids, although Eng and Noble (71) showed no appreciable 
change in the cholesterol content of myelin from the developing rat 
brain. The cholesterol and galactolipid content of myelin froim 
the developing human brain does not appear to vary with age (55,72 
73,74). 
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1.4.2. 
_"Pro-EZelin" 
and formation of the rýiyelin membrane: 
It hasý been suggested that some of the variations in myelin lipid 
composition are due to the presence of a "Pro-myelin" fraction. 
The preparation of myelin from the brains of animals up to 25 
days of age, creates special problems for the interpretation of 
results. Myelination proper, does not begin in the rat until 
about 10 days of age, at which time the first rings of myelin can 
be seen around the axon in electron micrographs. It is not 
until this time that myelin can be isolated. The material 
isolated using the normal method of myelin preparation was found 
to have a lipid composition that was different from that of the 
adult rat (see Table 1.4). 14yelin prepared from the young brain 
has a higher proportion of phospholipid and a lower proportion 
of sterol and galactolipid than the adult brain. The composition 
of myelin from young brains resembles that of endoplasmic rett-liculum 
and plasma metribrane rather than mature myelin. Davison and 
co-workers (75,76) proposed that the myelin prepared from young 
brains (early myelin) was a mixture of mature uqyelin and a "pro- 
myelin" fraction derived from the oligodendroglial cell plasma 
membrane which is involved in the formation of myelin. 
The "pro-rilyelin" fraction has also been called the inyelin-like 
fraction due to, its co-sedimentation with mature myelin in the 
preparation procedure. The "pro-qyelin" material has been 
prepared (77) and shown to be poor in cerebrosides and to contain 
a higher proportion of shorter chain fatty acids in the phosphogly- 
cerides than mature myelin. Further studies by Agrawal et al (78) 
showed that the material resembled myelin in enzyme activity but 
differed in that the basic protein was absent. 
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TABLE 1.4 
Changes in the lipid composition of rat brain myelin are shown. 
The figures for lipid content are expressed as % dry weight and 
for desmosterol as % total sterol. All other values are 
expressed as vit % of total lipid. Age is expressed in days. 
Taken from ref. 66. 
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"Early myelin" therefore consists of the "pro-myelin" and compact 
myelin fractions from the developing brain and the myelin-like 
fraction is probably a transition state between the oligodendroglial 
cell plasma membrane and compact myelin. The "pro-myelin" fraction 
may also contain some fragments of oligodendroglial cell plasma 
membranes. Rouser et al (72) comment that although it is 
acknowledged that lipid gain or loss during subcellular fraction- 
ation is possible, there has been little attempt to evaluate this. 
Values for myelin total lipid between 59 and 90% of the dry weight. 
have been obtained using human brains, using the method of Norton 
(60). Selective loss of either lipid or protein'during isolation 
could account for the range of values obtained. 
The proposed existence of a myelin precursor is supported by the 
occurrence of the myelin specific constituents, basic protein and 
triphosphoinoSi tide in rats only 1-2 days old. This is well 
before the period of maximum myelin deposition at between 10 to 
20 days and before any myelin with the mature lipid composition 
can be found 79). Also at this early stage lipid droplets can 
be detected in the glial cells which may serve as a source of 
lipid material for myelin formation since they are observed less 
frequently as myelination proceeds ( 80). Additional evidence 
for a myelin precursor which may be glial cell plasma membrane or 
microsomes comes from the work of Handel ( 81 s 82 ) and Baumann 
et al ( 83) on myelin deficient mutants. In the Quaking mouse, 
a genetic mutant in which myelin is never properly formed and the 
number of glial cells in the brain appears normal, there is a 
qualititive defect. 
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This defect can be correlated With a loss of metabolic differentiation 
shown by the failure of long-chain fatty acids to appear in 
cerebrosides. The Jimpy mouse, a different genetic mutant, studied 
by Mandel, has a decreased number of oligodendroglial cells and 
this gives rise to a decreased amount of myelin. Since normal 
myelin formation is prevented, other membrane componenlls such as 
proteins are degraded. 
Mokrash (56) suggested that there is a 'threshold' compostion for 
precursor myelin, perhaps similar to that of plasma membrane with 
its large percentage of phosphatidy1choline, v., hich confers on the 
membrane some degree of stability. From this composition tile 
membrane attains the mature composition by replacement and exchange 
of lipid molecules and the addition of myelin-specific proteins 
which may be required to initiate a spontaneous compaction process 
(indicated diagrammatically in Figure 1.3) 
1.4.3 Chanqes in the lipid composition of subcellular fractions other 
than Myelin: 
Although the composition of mouse brain microsomes does not change 
appreciably with age (65) the molar ratio of galactolipid to total 
phospholipid increases with age in rat brain microsomes, nuclei 
and mitochondrila, (72). The phospholipid composil-Jon of chick 
brain subcellular fractions also changes during development. 
As seen in the developing rat and rabbit brain (24), the amount of 
sphingonlyelin increases at the expense of phosphat-idylchol-ine. 
Cholesterol and desmosterol can also replace each other in membranes 
(84) and cholestanol can replace cholesterol (85)). 
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1.4.4. Changes in the fatty acid composition Of major lipid classes: 
The overall changes seen in the fatty acid composition of major. 
lipid classes in the whole brain have been demonstrated in sub- 
cellular fractions from developing brain. Skrbic and Cumings (32) 
showed that in the rat brain the increase in C 18: 0 and C 18: 1 is due 
to the high level of these two fatty acids in phosphatidy1choline 
in myelin. There is a general tendency for the chain-lengths of 
the fatty acids of phosphatidy1choline in all brain subfractions 
to increase with age (32). Tile fatty acid composition o, 
cerebrosides from subfractions of mouse brain has also been 
studied (86). 2-Hydroxy-fatty acids account for 80% of the myelin 
cerebrosides fatty acids and 55% in microsomal fractions. The 
majority of fatty acids in myelin are of chain lengths greater 
than C 20 whereas, In microsomes fatty . 
acids of chain length C 16- C 20 
predominate. 
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1.5 LIND METABOLISM M-THE D. ý--VELOPMC- BRUN 
Both in vivo and in vitro studies have been used in the elucidation 
of lipid r. -ýetabolism in brain tissue. Many of the early hypotheses 
of brain lipid metabolism originated from the in vivo incorporation 
of radioactive precursors into brain tissue. The precursor was 
usually administered by intraperitoneal injection, or via the carotid 
artery. In vitro studies of lipid metabolism involve fractionating 
brain tissue homogenates by differential and density gradient 
centrifugation and assaying the resultant fractions for enzyme activity 'y . 
1.5.1 In Vivo Incorporation of Lipid Precursors: 
The uptake of lipid precursors by the developing brain has been the 
subject of several reviews ( 87- 89). Early experimenters (90-95) 
concluded that lipids Could only be labelled during early life 
and in particular, during the period of myelin formation and the sloa 
incorporation of precursors into the adult brain was due to the 
metabolic stability of myelin lipids and the blood-brain barrier. 
M, ore recently, SmAth and Eng (96) supported the idea of a lov., rate 
of adult miyelin lipid turnover by estimating the hall-lives of the 
myelin phospholipids phosphatidylcholine, phosphatidylinositol and 
sphingomiyelin to be 41 days, 18 days and 250 days respectively. 
Ho%4ever, following intraperitoneal injection of labelled acetate 
and glucose (97) the rate of turnover, as measured by loss of radio- 
activity, was the same in both adult and %ýIeanling rats. 
The major criticism of experim-ents involving the uptake of labelled 
compounds from the circulation into the brain has been the concept 
of the blood-brain barrier. 
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In recent reviews, Dobbing (15,98) and Dhopeshwarkar (87,99) 
have rejected the idea of there being any physical restriction 
to lipogenic metabolites entering the brain. They argue that 
the entry of any component into the brain is governed by the 
metabolic properties and state of the tissue and not by any 
physi cal property of the capi 1 laries. The metabolic properties 
envisaged are: l. the many types of uni- and bi-directional active 
transport mechanisms; 2. the varying metabolic activities of cell- 
ular components which determine the net flux and exchange of 
material between the blood and the brain; and 3. the size of the 
precursor pool in the tissue. 
Results have been published ( 94, lQO -. 104) involving the 
incorporation of radioactivity into the cerebral lipids of adUlt 
animals which cannot be explained in ternis of myelin lipid stability. 
Short term experiments by Ansell and Dohmen (100)and Davlson and co- 
workers (101,104)shovied that inositides and phosphatidic acid were 
rapidly labelled with 
32 P- phosphate but other phospholipids were 
labelled more slowly. 
14 C-cholesterol remained for as long in the 
mitochondrial membranes as in myelin (102,103)and Davison and Dobbing 
concluded (94) that the time taken for the transfer of circulating 
32 
P- 
phosphate to enter the brain was less than its subsequent transfer 
from the acid-solqble phosphate pool into brain phospholipid phosphate. 
Thus, a slow flux of label through the lipids of adult brain tissue 
could be indicative of a low rate of de novo synthesis and not a1 Ga I 
rate of lipid turnover. 
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The use of intracerebral injection may overcome any selective 
uptake phenomena which may affect the incorporation of precursors 
into brain lipid following intraperitoneal and carotid injection. 
Ansell and Spanner (105,106)showed that ethanolamine plasmalogen 
and phosphatidylethanolar,, line were eXtensively labelled in all brain 
1.5.1.1 
subcellular fractions following intracerebral injection of 
14 C-ethanol- 
amine. Similarly, Jungalwala and Dawson (107) using a variety of 
lipid precursors ( 
32 P-phosphate, 14 C-glycerol and 
14 C-ethanolamine), 
sho, aed thai there was considerable labelling of phospholipids in the 
microsomal and myelin fractions of adult rat brain. The specific 
activity of microsomal phospholipid was higher than that of myelin 
initially, but by 20 days after intracerebral injection, the reduced 
specific activities were the same. Also, follok-Ang injection of 10 
day old rats, some label remained in the adult brain. These results 
together with those of Ansell and Spanner (105)indicate that there 
are two pools of lipid in myelin, one rapidly exchanging and the 
other turning over slowly, which can be labelled in the developing 
animal. 
It is probable, therefore, that the exchangeable pool Of myelin lipids 
is larger and more accessible than had been originally thought. 
llo, aever, Davison and Gregson ( 53) cautioned that the metabolically 
active pool of- c,. erebroside sulphate was only 0.2%. of the total. 
Effect of c5et upon the fatty acid composition of cerebral lipids: 
Although it appears that lipid exchange in brain tissue is a common 
phenomienon, the fatty acid patterns of lipids are only slightly 
affected by dietary constraints such as starvation or essential 
fatty acid deficiency. 
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Changes in the fatty acid pattern of lipids due to dietary 
effects, are reversed when the animal returns to a normal 
diet (108,109). Since only small changes in the fatty acid 
patterns could be detected, endogenous fatty acid synthesis or 
re-utilisation of pre-formed fatty acids must be major routes 
of fatty acid metabolism in the-adult brain (110). 
1.5.2 In Vitro Studies of Brain Lipid Metabolism: 
The in vitro activities of many brain enzymes and enzyme systems 
involved in lipid synthesis have been investigated. Cerebral 
lipid metabolism, which is of special importance because of the 
large amount of lipid found in the myelin sheath, is outlined in 
figure 1.8 . Investigators have used slices, 
homogenates and subcellular fractions in the elucidation of 
cerebral lipid metabolism. 
Although the synthesis of phospholipids from phosphatidic acid 
in the brain is well documented, little attention has been paid 
to the de novo biosynthesis and activation of the fatty acids 
whose ultimate fate is incorporation into complex lipids. Brady 
(111 ) showed f atty aci d synthetase acti vi ty in rat brai nin 1960, 
but the first report of age dependant changes in the specific 
activity of the enzyme was not published until 1972 (112). - 
Changes in the specific activity of rat brain acetyl CoA carboxylase 
during the peri'od of myelination, were not reported until 1974 (113). 
Because of this paucity of knowledge, it was decided that changes 
in the activi-ty of the enzymes, acetyl-CoA carboxyllase, fatty acid 
synthetase and palmitoyl-CoA synthotase would be investigated, 
primarily, in the developing rabbit brain. A brief consideration 
of the modes of action of these enzymes follows in section 1.5.2.1. 
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FIGURE 1.8 
simplified view of the routes of phospholipid synthesis. 
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Age dependant changes for the incorporation of fatty acid precursors 
into brain slices have been reported for both rat (114) and rabbit 
brain (115) and will be discussed in the light of results presented 
subsequently. 
The exchange- and turnover of nyelin lipids is only possible if it is 
mediated by some form of transport mechanism, since myelin is devoid 
of lipogenic enzyme activity and the microsomes are considered to be 
the site of lipid synthesis. Dawson (116)postulated that newly 
synthesized phospholipids are transferred to other cellular membranes 
and organelles by a process of exchange diffusion involving soluble 
cytoplasmic lipoprotein by a similar mechanism to that described 
in hepatic tissue (117,118). Such protein factors, similar to those 
described in liver cell phospholipid transfer (119), have been described 
for the transport of cerebral lipids (120-123). 
The catabolism of brain lipids is not clearlY understood-, although 
phospholipase A, activity has been found (124) and phospholipase A2 
activity has been recovered from acetone powder of brain tissue (125)- 
Both a sph-Ingomyelin specific phospholipase C (126) and a phosphatid-yl- 
ethanolamine specific phosphol ipase C (127') have been isolated From 
rat brain tissue. Ansell and Spanner (128,129) slmaed the presence 
of Mg 
2+ dependant plasinalogenase, hydrolysing the alkenyl ether linkage 
of ethanolaminvpl; smalogen, especially in the crude mitochondrial 
fraction of AM matter. Enzymes of triphosphoinositide breakdown 
have been found by Dawson and Thompson and co-workers (130-133)). 
The catabolism of fatty acids in the brain is uncertain, Since brain 
mitochondria are capable of oxidising fatty acid at the sar. -. e rate as 
liver mitochondria (1341. ) but the rate of in vivo fatty acid oxidati,, ý,,, 
as measured by the oxidation of radioactive fatty acid to 
14CO 
2is1 
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Warshaw et al (135) showed that fatty acid oxidation was highest in 
foetal and early neonatal life. This is in agreement with the accepted 
theory that glucose is the major energy source of the adult brain with 
a respiratory quotient of almost 1. 
1.5.2.1 In Vitro Fatty Acid '. Ietabolism: 
fluch information about the uptake-and incorporation of fatty acids 
and their precursors into brain lipids was obtained by studies in vivo. 
In Vitro experiments can be divided into two types : (i) Investigations 
into de noVO synthesis and (ii) the further metabolism of preformed fatty 
acids. 
(i) De novo synthesis of saturated fatty acid is catalysed by t, io 
enzyme systems which function sequentially in many biological systeims. 
The enzymes are : 1. Acetyl-CoA carboxylase and 2. Fatty acid synthetase. 
This aspect of fatty acid metabolism has been reviewed thoroughly 
recently ( 136-138 ). 
1. The first enzyme, acetyl-CoA carboxylase, has a biotin prosthetic 
group and the carboxylation reaction to form malonyl-CoA requires the 
formation of a carboxyl-biotin intermediate. The two step carboxylation 
reaction can be seen below 
(i) ATP + HCO 3t biotin enzyme = COp biotin-E + ADP + Pi 
(") C02-- biotin-E + CH 3 CO-SCOA =-OOCCH2CO-SCOA and biotin-E 
This enzyme has been purified from many sources but has not been invest- 
igated thoroughly in the developing mammalian brain. 
Acetyl-CoA carbox - ylase is frequently considered to be the rate limiting 
enzyme of fatty acid biosynthesis. Initial observations of the activity 
of the enzyme in liver extracts showed that acetyl-CoA carboxylase had 
a much lower activity than fatty acid synthetase. But when the carboxy- 
lase was fully activated in the presence of citrate and assayed under 
optimum conditions, its activity is similar to that of fatty acid 
synthetase. Therefore the degree of enzyme activation may be firilportant 
in the regulation of the in vivo rate of fatty acid synthesis. 
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The addition of citrate causes polymerisattion of ace-ývl-CoA 
carboxylase from animal sources, but not in yeast or bacteria. 
I The enzyme is competitively inhibited by palmitoyl-CoA 
-in- 
vi-tro 
with respect to citrate at physiological concentrations. The 
degree of this inhibition in vivo is hard -to estimate, as the 
cytoplasmic levels of free palmitoyl-CoA are not known. The 
activity of the liver enzyme is depressed in starved rats, rats fed 
a high fat diet or made alloxan diabetic and is elevated in rats 
'fed a fat-fýee diet. These changes of activity have been shci,,, n 
to be changes in enumes content. The rat brain enzyme has not 
been investigated under different dietary conditions, although it 
would be reasonable to suggest that there may be a change in 
enzyme content during the period of maximum lipid deposition during 
mye I in a ti on. 
2. The second step in the synthesis of fatty acid is their 
formation from acetyl-CoA, malonyl-CoA and NADPH by the multi-enzyme 
complex fatty acid synthetase. The generalised equation For the 
synthesis of fatty acids is : 
CH 3CO-SCOA+n HOOCCH 2-CO-SCOA+2n NADPH+2nH 
+H CH CO-SCOA+fICO 4EC 3(CH 2- 2)n-. 2 
+nH 20+nCOASH+2n NADP+ 
For synthesis of palmitate from acetyl-CoA: 
n=7 
The enzymes required for the synthesis of fatty acids from w. alonyl-CoA 
have been isolated from many unicellular organisms, plant and arlimal 
tissues. The multi-enzyme complex system was discovered by Lynen (139) 
in yeast, and subsequently comparable complexes have been isolated and 
purified from various avian and mammalian tissues (138). 
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The various intermediate reactions were elucidated using E. coli 
where the enzyme components exist as discrete units. Acyl-carrier 
protein (ACP) is a central component of all fatty acid synthetases, 
and contains a 4'-phosphopantetheine prosthetic group. The acyl 
intermediates in fatty acid synthesis are bound in thioester linkage 
to the SH group of the prosthetic group. The ACP from animal 
complexes has only been isolated as fragments and it appears that 
ACP is covalently attached to one of the two non-identical polypeptide 
chains that comprise the synthetases of the multi-enzyme complex type (140). 
Recent studies on mammary gland (141,142) and rat and rabbit liver 
(143,144) showed that fatty acid synthetase was more active with 
buýyryl-CoA as primer than with acetyl-CoA. 
Yeast fatty acid synthesis is terminated by the transfer of the acyl- 
chain from the SH -group of the 4' phosphopantetheine prosthetic 
group to CoASH. Termination of mammalian fatty acid synthesis 
in vitro results in the release of non-esterified fatty acids by an 
in-'t. rinsic mechanism. In E. coli a specific palmityl-ACP thioesterase 
has been isolated although its role in vivo is not clear since the 
ACP derivatives of the fatty acid products have been shown to be 
incorporated directly into phospholipids (137). 
Fatty acid synthe: tase undergoes short and long-term control, and 
this enzyme may ýe important in the long-term regulation of fatty 
acid synthesis. The effects of hexose diphosphates (145,146) and 
long-chain acyl-CoA derivatives on the enzyme do not appear to have 
a physiological role. 
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A regulatory role for the rapid turnover of the prosthetic group 
remains to be elucidated. Long term control of the content - of 
fatty acid synthetase appears to be exer-ILed by a variety of factors, 
nutritional, hormonal, genetic and developmental, although only 
developmental factors appear to affect fatty acid synthetase in 
the brain (145). 
3. From in vitro*studies of phospholipid metabolism, fatty 
acids are further metabolised in the presence of ATP and CoASH or 
as Acyl-CoA synthetase derivatives. Acyl-CoA synthetase has 
been investigated in sub-fractions from rat liver (14,7,143) and 
th6 highest percentage of total activity was found in the micro- 
somal fraction. Similar results were reported for the adult rat 
brain by Pande and Mead (149). Changes in the activity of this 
enzyme have not been investigated in the developing brain. 
The formation of fatty acids with a chain length longer than C16 
(the predominant product of brain fatty acid synthetase), is carri. -d 
out by both mitochondrial and microsomal enzyme systems (150). The 
mitochondrial system elongates fatty acids by the addition of acetate 
units from acetyl-CoA whereas the microsomal system is malonyl-CoA 
dependant (151). Baumann et al have identified at least 'I. Wo 
different malonylý-COA-dependant elongation systems located in the 
microsomes from the brains of normal and 'quaking' mice. Ammonium 
sulphate precipitation was used to separate active microso-mal 
elongation systems (152) but density gradient centrifugation has 
not been used. 
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1.6 Hormones and the Develo-p-1n. g Brain: 
Some behavioural changes affecting the fully mature brain are 
associated with hormonal imbalance. In these cases, normal adult 
behaviour can be restored by hormone therapy, but certain abnormalities 
are caused by lesions resulting from hormonal imbalance during certain 
periods in the development of the central nervous system and these 
are permanent. It was postulated by Pfeiffer (153) that the 
lorganizatign' (in terms of the formation of the fully developed 
functional brain) of the central nervous system is influenced by 
hormones acting at certain periods during the early development of 
the brain. Most investigations relate to the effect of adreno- 
co, rtical and thyroid hormones on the b. rain development of laboratory 
animals. 
The postnatal growth of the brain in most animals is due partly to 
cell proliferation. Different areas of the brain increase in cell 
number (as measured by DNA content) to a differing degree and at 
different rates. The adult rat brain cerebrum contains 80% more 
cells than. at birth and the increase in cell number is even greater 
in the cerebellum than in the cerebrum. 
The timing of cell proliferation also varies from region to region 
in the brain, In the rat brain, the rate of cerebral cell 
acquisition is rapi'd in the first 15 days after birth whereas in 
the cerebellum there is a period of slow cell multiplication lasting 
a few days. preceding extensive cell formation. Glial cell formation 
accounts for most of the postnatal increase in cell number (154). 
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Thyroid hormone is involved in the regulation of postnatal cell 
formation in the brain. Neonatal thyroildectomy causes a 
retardation in the rate of DNA increase, although normal cell 
'- rati on numbers are attained after sorne delay (155,156). Administ 
of triiodothyronine in early life also influences postnatal cell 
formation. This leads to a permanent reduction in cell numbers 
(157). 
Triiodothyronine increases the rate at which enzymes involved in 
glucose metabolism and amino acid formation attain adult activity 
in developing rats, but these enzymes are depressed in thyroid 
deficient animals (158). The biochemical observations of brain 
maturation can be related to the morphological effect of thyroid 
hormone. Thyroid deficiency causes a reduction in neuronal cell- 
cell interactions (159) and a reduction in synaptosomal enzyme 
-. activity and glucose metabolism (156). There is significant 
reduction in the amount of myelin deposited in the brain of the 
L, hyroidectomised rat (160) although this may be due to a decrease in 
axonal density (161). The administration of thyroid hormone in 
early life only increases the rate of myelination ill the initial 
stages. The effect of thyroxine on the activity Of most enzymes 
associated with myelin formation has not been studied. 11ye 1in 
formation in thyroidectomised rats is retardpd and the pea" 
incorporation of cerebrosides, sulphatides and cholesterol occurs 
between 22 and 30 days after birth, not-12 -- 18 days as in normal 
rats (162 ). 
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Corticosteroid administration causes a marked inhibition of cell 
multiplication in the rat brain, although no significant change 
in cell size was noted (163). Balazs et al (164,165) showed 
that various enzymes of nervous tissue have been induced prematurely 
by the administration of corticosteroids.. Volpe and Kishimoto 
(112) noted that rat brain fatty acid synthetase activity was not 
affected by hydrocortisone or triiodothyronine administration, but 
the enzyme from C6 glial cell culture was. depressed by glucocorticoids 
(166). Rat brain glycerol-3-phosphate dehydrogenase activity is also 
affected by glucocorticoids. Hypophysectomy leads to a 40% decrease 
in enzyme aýtivity (167). 
Corticosteroid or thyroid hormone treatment in early life-causes 
inhibition of postnatal cell development in the cerebrum by 30 - 40% 
but the appearance of substances (such as triphosphoinositides) used 
as indices of biochemical differentiation (165) was not affected. 
Thyroid deficiency, although it has no effect on cell formation in 
the cerebrum, produces retardation of enzyme activity. Since glial 
cell proliferation accounts for most of the increase in cell number in 
the cerebrum after birth, and cortisol and thyroid hormone cause a 
reduction in the nUTber of glial cells in the brain, it remains to be 
seen if these hormones play a role in the control of lipogenic enzymes 
associated with myelin formation. 
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MATERIALS AB ME ETHODS 
2.1 Materi al s.: 
2.1.1 CilromatoUraphy: 
Kieselgel H was obtained from E. Ilerck Laboratory Chemicals, Darmstadt, 
West Germany. Sephadex G25 was purchased from Pharmacia, Uppsala, 
Sweden. 10% Diethyleneglycol adipate - 3% phosphoric acid (DEGAP) 
precoated onto ChromasorbWwas supplied by Jones Chromatography & 
Company, Newport, Mon. . Standard fatty acid methyl esters were 
obtained from Applied Science Laboratories, Pennsylvania, U. S. A. 
I Lipid standards for thin-layer chromatography and fatty acid standards 
for gas liquid chromatography viere obtained from P. L. Biochemicals, 
Mifliqaukee, U. S. A. 
2.1.2 Radiochernicals : 
HaH 14CO 3'( 
3H-methyl) 
carnitine, (9,10- 
3 H) palmitic acid and 
(1,2(n)311) and (1.14 C) n-hexadecane were purchased from the Radio- 
chemical centres, Amersham. Bucks.. (1-3 
14 C) malonyl-CoA and 
(2- 14 C) malonyl-CoA, were supplied by Nea England Nuclear Chemicals, 
GMbH, Dreichenhain, I-lest Germany. 
2.1.3 Other Chemicals: 
ATIP, CoA, HADH2, NADPH2' NADP and oxaloacetic acid were obtained 
from Boehringer Mannheim, GI-IbIl, Mannheim, West Germany. Dithiothreitol 
was purchased from Sigma Chemical Company, St. Louis, U. S. A. 
Crystalline bovine plasma albumin was supplied by Armour 
Pharmaceutical Company Limited, Eastbourne, Sussex. L-carnitine , 
thyroxine, propylthiouracil, heparin and the scintillation chemicals 
2,5-diplienyloxazole (PPO) and 1,4, bis-2-(5-phenylo,, azolyl) bell zene ( POPOP) 
were obtained from Koch-Light Laboratories Limitc-d, Colnbrook, Bucks.. 
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Basic scintillator was obtained from Intertechnique. All other 
chemicals, of A. R. purity, were obtained from either British Drug 
Houses, Poole, Dorset or Fisons Scientific Apparatus Limited, 
Loughborough, Leics.,, 
2.1.4 
Air, nitrogen, hydrogen and 95% argon/5%CO 2 mixture were purchased 
from British Oxygen Company, and methane from British Oxygen Company 
or British Prug Houses. 
Animals: 
Rabbits were of the New Zealand White strain (albino) supplied by the 
Gadsby Animal Farm, Penistone, Yorks. Adult rabbits were of the 
female sex, while younger rabbits were of both sexes. SuCkling 
rabbits were removed from the mother immediately before killing. 
Weaned rabbits were fed ad libitum on a diet of water and Coney 
Pellets (BOCM, Stoke Han'deville, Bucks. ). The pellets had the 
following fatty acid composition (expressed as a percentage of the 
total fatty acids) palmitic, 13: palmitoleic, 0.5: Oleic, 27: 
linoleic, 7: arachidonic, 4. 
Wistar rats from the University colony, were fed ad libitum on a diet 
of ratcake and wateK The diet was Oxoid Modified Diet 86 
Iý 
obtained from HI Ityles (Bewdley) Limited, Tewdley, Worcs. Adult 
rats were in the weight range of 150-200 gm. and females were used at 
all ages except in the thyroid hormone studies. Pregnant rats 
used in the thyroid hormone studies were kept ir, the Animal House 
for the duration of the study, and fed pasteurised diet fron; the 
above source. 
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These rats were supplied with the exac-L. date of conception known. 
This was determined by the Animal House staff looking. for vaginal 
'plugs' which are released by the female after mating has taken 
place. The average size of the litters used was t1aelve. Bovine 
and calf liver used for the preparation of carnitine acyl transferase 
was obtained from the local abattoir and transported to the laboratory 
on ice. 
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2.2 
2.2.1 
METHODS 
Preparation of Subfractions from Whole Brain: 
Animals were killed by cervical dislocation. The whole brain was 
quickly removed, chilled and weighed. For ages up to fifteen days, 
six brains from littermates were homogenised together, but fewer 
brains from older animals were combined. Foetuses i-iere delivered 
by caesarian section immediately after the death of the mother. Only 
foetuses from the last third of gestation were used. 
Whole brains were homogenised in ice-cold medium in the ratio . of 
1: 2 (W: V) using a motor-driven Potter-Elvehjem homogeniser with a 
teflon pestle, clearance O. lmm (15 passes). The homogenisation 
medium used contained 0.314 sucrose, 0.251.1 potassium phosphate and 
l0afl dithiothreitol at pH 6.8. Early experiments showed that the 
activity of palmitoyl-CoA synthetase was lower if the tissue was 
fractionated in sucrose alone. Dithiothreitol was added to prevent 
oxidation of the -SH groups_of the proteins. 
The scher., io used for the subfractionation of brain tissue was a 
modification of that reported by Gray and Whittaker (38) outlined 
diagrammaticallyin Fiqul-E, 2.1. The method used differed from the 
original in that. the first pellet was resuspended in hom. ogenisation 
medium and recentrifuged four times at 8000 gmin. , as reported by 
Lapetina (168). . 
This reduces any mitochondria or cytosol 
trapped in the pellet. 
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FIGURE 2.1 
Flow diagram. for the preparation of brain subfractions by 
differential centrifugation. 
All values ore given as gmin or gx minutes and the fractions 
prepared are labelled : 'crude' Fl, Fls F2, F3 and F4. 
Figure2.1 Centrifugation scheme for brain 
subfraction preparation . 
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All manipulations were carried out at 40C using ice baths and 
refrigerated centrifuges. All centrifugation steps involved in 
the preparation of the F, fraction (see Figure2.1) were carried out 
using the high-speed attachments of the IISE Mistral-6L. Fractions 
F1 2, F3 and F4 were prepared by centrifugation in the 10 x 10 ml. and 
the 8x 50 ml. rotors of the MSE Superspeed 50 or the 50 and 30 
rotors of the Beckmann Spinco L-2 ultracentrifuges. There was no 
observable difference in the results obtained using either of these 
centrifuges and the use of either one depended upon availability. 
Subfractions were made up to known volumes , -Jth hom. ogenisation 
medium and either assayed immediately or stored at -20 
0 C. 
Fractions were designated as follows : 
F, plasma membrane, nuclei , and heaKy myel in 
F2 mitochondria, synaptosomes and light myelin 
F3 microsomes 
F4 soluble fraction 4 
The contamination of the fractions by other subcellular particles 
I 
will be discussed in the results. 
Fractions F, and F2 were further subfractionated by sucrose density 
gradient centrifugation (Section 2.2.2). The effect of (1) freezing 
and thawing, (2) sonication and (3) osmotic shock on these fractions 
has also been determined by density gradient centrifugation. 
(1) Freezing and thawing was carried out in either test tubes 
or plastic vials. Up to 2 ml. of sample, containing 
100 mg. protein, was first immersed in liquid nitrogen 
until frozen and then transferred to a viater bath at 300 
Until it thav., ed. SHEFFIELD 
UNIVERSITY 
LIBRARY 
JIILI I ILLv 
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This was repeated four times before the sample was 
layered on a gradient. 
(2) Sonication was carried out using an HISE sonication model 
150 W. Full power was applied to the sample for a total 
of one minute in sessions of 15 seconds. The sample 
was sonicated standing in an ice bath to prevent overheating 
and subsequent protein denaturation. 
(3) Samples were subjected to an osmotic shock by resuspending 
pelleted F, or F2 material in ten volumes of distilled 
water. A motorised homogeniser was used to resuspend the 
pellets. The samples were then left on ice for one hour. 
After recentrifugation the samples were resuspended in 
homogenisation medium. As a control, aliquots of the same 
samples were subjected to the same treatment using homo- 
genisation medium throughout. 
2.2.2 Sucrose Density Centrifugation- 
ýucrose density gradients were formed at rocm temperature using either 
a double-well perspex gradient mixer, with one well used as a mixing 
chamber, or a three-. channel Pharmacia pump (Model P-3), Both methods 
gave good reprodu cible linear gradients, when checked using a 
refractometer, although the use of the mixer was later discontinued in 
favour of the pump since it was possible to make two gradients 
simultaneously. Gradients were formed with 0.5M sucrose containing 
0.25f, I potassium phosphate pH6.8 as the starting solution and 1.514 
sucrose containing 0.251.1 potassium phosphate pH 6.8 as the limiting 
solution. 
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LOM sucrose/phosphalCe solution was also used as a limiting solution. 
Different sized gradients were formed in tubes for the Beckmann 50 
rotor (8 ml) the Beckmann S14 41 (12 ml) and tile MSE 3x 25 ml (20 ml) 
swingout rotors, the figures in brackets refer to the size of gradient 
formed in each tube. 
Gradients were prepared before the preparalklion of subcellular fractions 
F, and F2, and left for two to three hours to equilibrate before use. 
Up to 0.5 ml* of resuspended F, and F2 containing up to 25 mg. protein, 
were loaded onto the 8 ml. and 12 ml. gradients and up to 1.0 ml. onto 
the 20 nil. gradient. 
After centrifugation, bands were removed by three different methods : 
Bands were removed sequentially down the gradient by a 
manual process using a Pasteur pipette. The disadvantage 
of this method was that some material from each band was 
observed to have been left behind, and i'n cases where bands 
were very close together, cross-contamination could occur. 
(ii) The LKB sucrose density gradient fractionator vf, hich pumps 
out the gradient from the bottom of the tube, was found 
to be unsatisfactory because passing the central stainless 
steel outflow pipe through the gradient caused some 
4ck bands tended not disturbance of the bands. Also thl 
to pass through the pipe and adinered to the outer surface 
and tended occassionally to block the pipe. 
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(iii) The MSE unloader was found to be more satisfactory than 
the LKB model. Heavy 2.0M sucrose was pumped through a- 
central pipe to the bottom of the centrifuge tube and this 
displaced the gradient, finally pushing it through the 
perspex cap and out through a plastic tube to the collecting 
tubes. Although the cap was made of perspex, it was not 
possible to see when each band reached the top of the 
centrifuge tube, passed through the cap and out to the 
collecting tubes, due to the optical properties of the 
machined perspex. In common with the previous method, 
material adhered to both the perspex cone and the delivery 
tube and it was found that large particles of agglutinated 
membrane appeared in fractions that were expected to be 
clear. 
Fractions obtained from the gradient were analyzed, either straight 
from the gradient, or after dilution with distilled water, to give a 
final sucrose concentration of 0.314, or dialysis against the homo- 
genisation medium. 
2.2.2.1 Development of Conditions for Continuous Sucrose Density Gradient 
Centrifuqation: 
Samples of freshly-prepared F1 fraction in 0.314 sucrose, were applied 
11 to continuous sucrose density gradients in the range 0.5[4 to 1.51 
sucrose. Initially, these gradients were 8ml in volume and were 
run in the Beckmann 50 fixed angle rotor. The shortest centrifuge 
run was for one hour at 50,000g (3 x 1069min) and this gave lo--a 
resolution of three bands on the 8ml gradient. 
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The speed was increased to 63,000g for one hour (3.8 x 106 gmin) 
which was used by Heri-iminki and Suovaniemi (169) to separate plasma 
membranes on discontinuous gradients. At this speed, four bands 
were observed. Increasing the running time only slightly increased 
the resolution and above two hours no difference was observed. 
Increasing the speed of the centrifuge did not improve the separation 
in the 8ml gradient (See Figure 2.2 ). 
The diagramiatic representation of the gradients in Fig. 2.2 shows a 
thick band (band two ) tailing off on one side. 
This was caused by using a fixed 
angle rotor. The centrifugal force is applied diagonally acrosss 
the tube and some of this fraction has, remained adhered to the wall 
of the tube after completion of the centrifugation. In. differential 
centrifugation, this phenomenonslightly disrupts the orderly 
sedimentation of particles and so could perturb a sucrose gradient in 
density gradient centrifugation. 
S1441 swingout rotor was used. 
Because of this, the Beckmann 
Using 12ml gradients, it was found 
that best resolution was obtained at 100, OOOY for ninety ninutes 
(9 x 106 gmin). The bands were broader than before because of the 
shallower gradient (see Figure 2.3a. ). Figure"2.3b. sho-. as lChe 
separation obtained on 20, mi gradient at 100,000g for nine-'L-. y minutes 
(9 x 10 
6gmin) T- his gradient was used extensively in the analysis- 
of fractions following intracerebral injection since it was possible 
to load more material onto the larger gradient and the bands viere 
very sharply defined and so helred to reduce cross- contami nation. 
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PTMIPF 99 
Diagrammatic representation of the results of fractionation of F, 
by. sucrose density gradient centrifugation. 
Centrifugation-conditions are giv en in gx minutes from 50,000 xg 
for 60 minutes to 63,300 xg for 120 minutes. The three bands 
obtained retain the same identification throughout. The gradients 
were linear from 0.5M to 1.51M sucrose buffered with 0.25'11 potassium 
phosphate at pH 6.8. The tailing of band 2 is caused by the use of 
a fixed angle rotor. 
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The material recovered from density gradients was designated. 
according to its original source (eg: Fl) and the position of tile 
band on the gradient (eg: 2) giving rise to fractions F 12 etc. 
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2,2.3 
2.2.3.1 
PREPARATION OF ENZY14ES 
Preparation of carnitine_palmitoyl transferase (EC. 2.3.1.2-. ) 
Palmitoyl-CoA : carnitine palmitoyl transferase was prepared using 
the method of Norum (170). Bovine and calf liver were used in two 
separate preparations of this enzyme. The washed mitochondrial 
pellet was prepared and resuspended exactly as described by Norum 
and stored at -20 
0 C. Small aliquots of this were taken and - 
purified to yield a crude carnitine palrilitoyl transferase fraction. 
The suspenýion of the freeze-dried extract obtained in the final 
stage of the preparation was spun in a bench top centrifuge and 
the transferase activity in this fraction was assayed using a 
radioactive carnitine exchange reaction (171). The equation for 
this reaction is as follows 
palmitoyl-carnitine + CoA +3 H-carnitine 
palmi to yl-CoA + carnitine +3 H-carnitine 
palmitoyl_3 H-carnitine + CoA + carnitine 
The incubation mixture contained in a total of 1.0 ml : 
0.5nfl palmitoyl (L)-carnitine, 0.12mM CoASH, 0.2mM (3 H-Me) carnitine 
(1ci/mole) , 2W dithiothreitol, lOOrrM Tris-VCl pH7.5, protein and 
water. All incubations were carried out in duplicate in a shaking 
water bath at 30 OC. The reaction was started by the addition of_ 
protein and stopped with O. lml of concentrated HC1. Radioactive 
palmi toyl- carni tine was extracted with I. Oml of n-butanol after the 
addition of 0.9ml distilled water. The butcabol fraction was 
removed by Pasteur pipet-'(, e and .. iashed with 2ml butanol- saturated viater. 
0.2ml of this fraction was taken to dryness in a scintillation vilal 
and the radioactivity determined. The enzyme preparation W&S Used 
in the assay of palmitoyl-CoA synthetase. 
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2.2.4 
2.2.4.1 
PREPARATION OF SUBSTRATES 
Preparation of defatted bovine serum albumin: 
The solutions of defatted bovine serum albumin prepared (172) [lad 
protein concentrations of 70-90 mg/ml and were stored at '200C and 
diluted as necessary. 
2.2.4.2 Preparation of potassium palmitate solutions: 
Equimolar amounts of palmitic acid and potassiui-ii hydroxide %,,, ere 
used to giye a final solution of 5M potass-lum palmitate. The 
solution was stored at 40C and warmed to 300C before use. 
2.2.4.3 Preýaration of acetyl-CoA: 
A modification (173) of the method of Ochoa (174) was used in the 
preparation of acetyl-CoA. The yield was determined by measuring 
the appearance of free-SH groups (see section 2.2.6.4) after hydro- 
lysis of the thioacyl bond by 0.214 KOH. The yield (routinely greater 
than MZO) was calculated by subtracting the amount of unreacted COASH, 
determined by the free-SH concentrate before hydrolysis, from the total 
-SH concentration after hydrolysis. 
2.2.4.4 Preparation of 
This was routinely prepared by the method of Trams and Brady (175) 
by firstly synthAising monothiopheny1malonate and then reacting this 
with CoASH. Care was taken to eXClL. de traces of water by passing 
the nitrogen through a calcium chloride drying tube before entering 
I> I- the reaction vessel, and by only using 
freshly redistilled dimethyl 
formamide and thiophenol. 
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The yield of monothiophenylmalortate was estimated from its absorbance 
2.2.4.5 
at 237nm in absolute ethanol. This intermediate was stored at 
40C and found to be stable for several months. Malonyl-CoA was 
prepared by reacting excess (20 pmol) monQthiophenylmalonate with 
10 Pmol CoASH. in 0.114 bicarbonate solution at p1l 8.3 at 4()C. A 
gentle steam of nitrogen was passed through the reaction mixture. 
Unreacted intermediate and thiophenol were removed by extraction with 
diethyl ether, and the yield (percentage bou nd to CoASH) .. ias estimated 
as for acetyl-CoA. 
It was found that malonyl-CoA was stable for several weeks but it 
was ( usually prepared just prior to use. Both accetyl- and malonyl-CoA 
were used without further purificatibn. 
Preparation of palmitoyl L-carnitine: 
Palmitoyl chloride and free L-carnitine were used in the preparation of 
palmitoyl-carnitin; according to the method of Bohmer and Bremer (176) 
Palmitoyl chloride was prepared by refluxing 500 mg palmitic acid 
with 15 A thionyl chloride. Unreacted thionyl chloride was removed 
. 111 at room temperature under a gentle strean. of d1.1 nitrogen until constant 
weight was reached. Immediately on preparation, the acyl chloride 
was mixed with a solution of 300mg L-carnitine in 0.5 ml trifluoro- 
acetic acid in aitest tube fitted with a calcium chloride drying tube 
and left in a water bath overnight at 40-450C. Isolation of 
palmitoyl carnitine was carried out as described (176). 
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2.2.5 ASSAY OF EIKYTIES 
One unit' of enzyme activity is defined as the amount of enzyme 
required to convert I nmol of substrate to product per minute, 
All assays were carried out in duplicate at 300 C in a shaking water 
bath. Spectrophotometric assays were carried out at 30 OC as 
described in section 2.2.5.4. All enzyme assays used were checked 
for linearity vii-th respect to protein and time. 
2.2.5 -1- Fatty acid synthetase: 
Fat-', -y acid synthetase was assayed in subcellular fractions by the 
method of Volpe and Kishimoto (112). The final volume of each 
incubation was 0.5 ml and contained 40mll potassium phosphate pH 6.4, 
130 p. 11 PIADPH, 60-p', l acetyl-CoA, 16NM ( 
14 C) malonyl-CcA (either 2- 
14 C 
or 1 3- 
14 C, 0.5 Ci/, -r. ol ), 4414 EDTA, 3mM dithiothreitol and up to 
2r,. q p rotein. The reaction ulcas initiated by the addition of the 
protein and stopped by the addition of 4A chloroform: methanol 
(2: 1 v/v), after 5 and 10 minutes. Lipids were extracted using 
the mthod of Folch it a! (177)(See methods section 2.2.7). A 
portion of the lipid extract was taken to dryness at room temperature 
in a scintillation vial and the radioactivity determined by liquid 
scintillation counting (see section 2.2.6.4). The radioactive 
products were analysed by, thin-layer and radiogas - liquid chromato- 
graphy. 
Z-2.5.2 Ace>l-CoA carboxylase (EC 6.4.1.21. ): 
This enzyme was assayed in the. F4 fraction of brain homogenat, es using 
the ri,. ethod of Gross and Nlarshavi (113) which was a modiNcallion of 
L that', of Greenspan and Lowenstein (178). This method vias developed 
specifically for "the assay of rat brain ace-L. Yi-CoA carboxylase. 
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The enzyme was preincubated at 30 0C for 30 minutes in a shaking 
water bath in a medium (0.5 ml) containing 40m. ',, l Tris-HCI plil 7.5, 
20m! 4 t"gC'2,8mll sodium citrate 4mM EDTA and 2 mg defatted bovine 
serum albumin, 
(using 
- up to 2 mg brain supernatant protein). 
The assay was started by the addition of 0.5ml medium containing: 
40mll Tris-HC1 pH 7.5 20nfl MgC'2,8mM sodium citrate 4n, l ATP, 
0.8m; N1 acetyl-CoA and 160mll-I NaHCO 3, containing NaH 
14 C03 (SPec'f'c 
activity 0.05Ci/rr-ole). The complete mixture was then incubated 
for intervals up to 15 minutes at 30 0C and terminated by the 
addition of 0.1 ml 10% tricholoracetic acid. The samples wore 
then centrifuged in a bench-top centrifuge to sediment the protein. 
Theisupernatant was then remo 
. 
ved and dried down in a scintillation 
vial under a stream of hot air to remove 
14 C-bicarbonate. Radio 
activity was determined by liquid scintillation counting. See 
section 2.2.6.4. This method was used for both the "crude" 
supernatant fraction and that purified by filtration through a 
Sephadex G-25 column to remove low molecular weight compounds. 
2.2.5.3 Palmitoyl-CoA synthetase 
_(EC 
6.2.1.3): 
This enzyme was assayed by the method of Farstad et al. (179) and 
is bas ed on the conversion of palmitoyl-CoA to palnlitoyl-( 
3 H) carnitine. 
Incubations were carried out at 300C in a1 ml system containing: 
10OUI Tris-I]Cl-pH -7.5, SOpM CoA, 3.0mM dithiothreitol, 1.5rr, '4 ATP, 
0.4d, '. potassium palmitate, 3mg defatted bovine serum albumin, 
2niNI MqCl 2' 5m, 'l . _(3H-1-le) carnitine (O. lCi/mole), excess paln. itoyl-CoA 
carnitine palmitoyl transferase and prot6in from the full homogenate 
or subcellular fractions. 
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The reaction was started by the addition of ATP, and stopped with 
0.1 ml concentrated HCI. Palmitoyl-( 
3 H) carnitine was extracted 
by either the method of Bremer (180) or Solberg (171). The former 
method required the addition of 0.9ml of distilled water and 1.0 ml 
n-butanol and thorough mixing before the upper phase, which contained 
radioactive palmitoyl carnitine, was removed and washed with butanol- 
saturated water. The latter method required the addition of 0.9 ml 
saturated ammonium sulphate solution and 1.0 ml iso-butanol saturated 
with ammonium sulphate. There was no observable difference in the 
results obtained by either method. Radi o acti vi ty was determi hed by 
liquid scintillation counting after evaporation of 0.2 ml of the 
washed non-aqueous fraction. 
2.2.5.4 Glucose-6-phosphate dehydrogenase (EC 1.1.49): 
0 
Glucose-6-phospha't. e'dehydrogenase was assayed in subcellular'fraetions 
of the brain by the*method of Baumann (181). The system contained 
in a final volume of-2.5ml: 0.15m14 Tris-HC1 pH 7.5,1OPM IIgcl 23 
O. llil, l NADP, 100-1 glucose-6-phosphate, protein and water. The 
reduction of NADP was followed at 340nm at 300C in either a Gilford 
Model 2410 or, Pye SP1800 recording spectrophotometer. The 'reaction 
was started by the addition of glucose-6-phosphate after a steady 
background rate had been recorded. 
ý2-2.5.5 Malate dehydrogenase: NAD Dependent (EC 1.1.37): 
Malate dehydrogenase was assayed (lM ) using oxaloacetic acid and 
NAW. The reaction mixture contained in l. ml: 200M potassium 
phosphate pH 7.5,1.5rfi-I oxaloacetic acid 0.7myl NADH and protein 
frorr, brain subcellular fractions. The reaction was started by the 
addition of oxaloacetic acid after a steady background rate had been 
recorded. The reaction was followed at 340nm using a recording 
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spectrophotometer. 
NON-ENZYMIC DETERIIINATIONS 
Determination of protein concentration: 
Protein concentration was estimated in the crude honloqenate and all 
subcellular fractions except the microsomal fraction using Biuret 
reagent (183). Protein, from a known volume of each fraction, was 
precipitated using 10% trichloroacetic acid and the samples were (5%f inal conc. ) 
centrifuged. The supernatant was carefully decanted and the pellets 
%qere suspended in 1.0 ml distilled water and mixed with 2.0 ml Biuret 
reagent. . The samples were incubated at 300C for 30 minutes for full 
colour development. The optical densities of the samples were read 
at 555nm together with blanks containing no protein, in either Pye or 
Gilford spectrophotomaters. The protein concentration was determined 
by reference to albumin standards in the range of 1-10mg protein/ml. 
Since this assay is not sensitive at low protein concentrations the 
Lowry-Folin method (184) was used to determine the protein concentration 
of the microsomal fractions, which contained in the order of lmg/ml 
protein. This method also avoids the use of large amounts of protein 
in the assay, requiring only 25-300jig protein. The assay was carried 
out exactly as described using freshly made up solutions and the samples 
were read at 750nm together with albumin standards and protein-free 
blanks. 
2.2.6.2 DNA estimation: 
DIIIA concentration %, ýas estimated by the method of Burton (185). Sampl es 
of full homogenate were hydrolysed in 10% TCA'and made up to 1.9ml 
with distilled water. 0.1 ml 70% Oerchloric acid was then added. 
After thorough mixing 2. Oml of diphenylamine---, cetylaldehyde reagent was 
added, mixed, and the samples left for 18 hours at room temperature. 
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The absorbance of the samples, hydrolysed calf thymus DNA standards 
and DNA-free blanks was determined at 600nm. 
2.2.6.3 Free thiol groups: 
SH groups were determined using the Jocelyn method (186). 0.1 ml 
sample was added to 0.9 ml distilled water and mixed before the 
addition of 1.5 ml, 50r,, J-1 potassium phosphate pH 6.8 and 0.5 ml 
disulphide reagent (0.4gm dithiobisnitrobenzoic acid (DTNB) in 
100 ml 0.214 potassium phosphate pH 6.8). Samples and blanks were 
left for five minutes before the optical densities were read at 412nm. 
CoASH was used as standard in the range 1-10 pmole. 
2.2.6.4 Determination of radioactivity: 
Radioactive samples in chloroform or chloroform: methanol (2: 1), from 
the assay of fatty acid synthetase and from the fractionation of brains 
-removed from animals after intracerebral injection (see section 2.2.8), 
were taken to dryness in scintillation vials before the addition of 
scintillation fluid. These samples afterdrying down, were counted 
in 10 ml xylene scintillator containing 5.0 gm PPO and 0.5 gm POPOP 
per litre xylene.. Samples containing water or n-butanol were counted 
in 10 ml Triton-toluene scintillator (1: 2 v/v) containing 4.0 gm PPO 
and 0.2 gm POPOP in 1 litre. Butanol samples, after solvent evaporation, 
were not counted.. in-xylene scintillator as they were found to contain 
a small quantity of water and this produced a cloudy emulsion which 
gave rise to variable counting efficiency. 
All samples were counted in a Packard liquid scintillation spectrometer 
model 3385. The counts per minute (cpm) were converted to 
disintegrations per minute (dpm) by the application of quench curve 
correction obtained by the external standard ratio method. Quench 
curves were generated by the addition of 0-100pl chloroform to 
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standards containing 69 x 10 
3dpni (3H) or 30 x 103 dpn, (14C)_-hexadacane. 
2.2.6.5 
2.2.7 
2.2.7.1 
The data was fed into a Wang desk top computer model 700, and the 
generated curves were stored on tape cassettes and then used to convert 
cpm to dpm, by reference to the external standard ratio The 
programme for the Wang computer for single-label counting was written 
by Dr. T. Hoy. Data was obtained from the counter as punched tape 
and was processed by the computer using a punched tape reader. 
Determination of radioactivity in the carboxyl carbon: 
The method of Brady et al was used in this determination (187). 
Extracted fatty acids were decarboxylated via the Schmidt degradation 
using concentrated H2 so 4 and sodium azide. The labelled carbon 
dioxide liberated was trapped in basic scinti'llator Intertechniqýe. 
LIPID EXTRACTION AND ANALYS)IS 
Folch extraction proced. urd: 
The Folch method (177) of extraction was used to extract all radioactive 
lipids, both from the assay of fatty acid synthatase, and from brain 
subfractions obtained after intracerebral injection. All samples 
were extracted with 2: 1 chloroform: methanol (v: v) and the volumes 
were adjusted to-give the Folch extraction ratio of chloroform: methanol: 
water 8: 4: 3. The upper phase was washed twice with synthetic 
lower phase and theý. combined lower phases were washed once with 
synthetic upper phase before being dried down under nitrogen or by 
rotary evaporation under partial vacuum. The lipid sampleswere 
then dissolved in a knoan volume of chloroform and aliquots were taken 
for analysis by thin-layer chromailography, and gas-liquid chromatography 
and for the determination of radioactivity. 
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2.2.7.2 Thin-layer chromatography: 
Thin-layer chromatography was carried out on 20cm x 20cm glass 
plates spread with a layer of Kieselgel-H 0.6mm thick. The plates 
were activated for one hour at 1000C before use and were pre-run in 
I 
petroleum ether: diethyl ether: acetic acid, in the ratio 75: 25: 1 
before the application of samples (188). Samples were applied 
to the plate in a small volume of chloroform using capillary tubes. 
The position of each sample on the plate was determined using a 
Shandon spotting guide. Purified standards were also run with the 
samples in order to identify the separate spots. The standards 
for the identification of neutral lipids were cholesterol stearate, 
glycerol tripalmitate, palmitic acid, cholesterol glycerol dipalmitate.. 
glycerol monopalmitate and lecithin (phosphatidyl choline). Rf values 
were 1.0,0.8,0.55,0.4,0.42,0.2,0, respectively. The solvent used 
was petroleum ether: diethyl ether: acetic acid 75: 25: 1 (188). 
Phospholipids were separated using a solvent containing chloroform: 
methanol: water in the ratio 65: 25: 4 (188). Phospholipid standards 
used were phosphatidy1choline, phosphatidylserine, phosphatidylinositol, 
phosphati dyl ethanol ami nq, sphingonlyelin and phosphatidic acid. Rf values 
we re 0.6, OA, 0.3,0.83,0.29, -and 0.88 respectively. 
The separated lipids were visualised by brief exposure to iodine 
vapour. The radioactivity in each spot was determined using a 
Berthold thin-layer scanner. - The areas under the peaks on the trace 
from the thin-layer scanner, were calculated and the relative 
percentage of radioactivity of each lipid class was calculated. 
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The method used to separate phospholipids depended upon the amount 
present in the sample. In a neutral lipid solvent, phospholipids 
remained at the origin and were eluted from silica gel scraped from 
the origin of the chromatogram, with chloroform: methanol (1: 1 v/v). 
The eluate was then concentrated and applied onto a new chromatogram. 
The recovery of phospholipid from silica-gel was 50-60/0'. 11 there 
was insufficient material to allow neutral and phospholipids to be run 
on separate chromatograms, the neutral lipid chromatogram was rerun 
in the more'polar phospholipid solvent. In this solvent, the neutral 
lipids run with the solvent front and the formerly immobile phospholipids 
were partitioned. There was no interference from the neutral lipids 
and material was not lost in this method. 
2.2.7.3 Gas-liquid radiochromatography: 
The radioactive fatty acid composition of the products extracted from 
the assay of fatty acid synthetase was determined by gas-, liquid 
radiochroi-iiatography. Samples were firstly saponified with W KOH 
at 1000C for 10 minutes and then extracted with Petroleum ether. . 
Unesterified fatty acids in petroleum ether were I'Llien taken to dryness 
in screvitop vials and methylated using 0.2 ml boron trifluoride in 
methanol at 600C for 5 minutes (189). The samples were then 
cooled on ice and 0.5 ml distilled water was added and the methyl 
esters were extracted with pentane. The lower phase was extracted 
Nice with 0.5ml pentane and the cobined extracts were taken down to 
1OV1 under nitrogen. The methyl esters. were then injected onto a 
gas-liquid chromatograph. 
To ensure the quantitative transfer of radioactive fatty acids and 
methyl esters a carrier containing equimolar quantities of standard 
fatty acids was added to the samples before saponification. 
57 
The carrier contained 10ýmole of the following fatty acids 
C 10 : 0, 
C 12 : 0' 
C 14: 0' C 16: 01 C 16: 1' C 18: 01 C 18: 1, 
C 18 : 2' 
C 18 : 3' 
C 20: 0' C 20: 11 and C 22: 0' 
A standard mixture of methyl esters was also injected onto the GLC 
before running radioactive samples to check the separation of each 
fatty acid methyl ester and make it-possible to identify the 
constituents of the samples by reference to retention times. The 
gas-liquid chromatograph used was a Pye 104 with a Panax radiogas 
detector unit, equipped with a gas proportional counter. The 
proportional counter measured the amount of 
14CO 
2 in the gas, stream 
after combustion of the methyl esters in a combustion tube packed 
0 with copper oxide at 300 C. The system employed a stream 
splitter at the end of the GLC column before the H2 flame ionisation 
detector with a ratio of 1: 5, therefore 20% of the column effluent 
went t. o the mass detector and 80% of the column effluent passed 
through the combustion tube. The 48 inch column was packed with 
a stationary phase of 10% diethylene glycoladipate -3% phosphoric 
acid (DEGAP) on a support of chromasorb W. The ýas phase was 95% 
argon/5% carbon dioxide at a" flow-rate of 40ml/min. Samples were 
chromatographed at an oven temperature of 1800C. The amplified 
signals from the ionisation detector and the gas proportionall counter 
were continuously monitored and superimposed using a two-pen recorder. 
The radioactivity in each sample was quantitated by using a scaler/ 
timer-with an attached printer. The radio-active peaks we re 
identified by direct comparison with the mass trace and reference to 
the retention times obtained with the standard mixture of methyl -esters. 
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2.2.8 
2.2.9 
INTRACEREBRAL INJECTION OF SODIUM (9,10_3[1) PALMITATE 
The radioactive palmitic acid was converted to the sodium salt by 
the addition of an equimolar quantity of sodium hydroxide to give 
a final concentration of 201, mole/ml and specific radioactivity of 
50OCi/mole. In two separate experiments, two groups of rabbits 
(littermates) of 10 and 24 days of-age were injected intracranially 
with O. lml of the palmitate solution at a point midway between the 
ears and to a depth of 5mm. The depth of injection was controlled 
by fixing a'plastic sheath to the syringe body which covered the . 
needle except for the final 5mm of its length, and therefore gave a 
reproducible depth of injection when the sheath was in contact with 
the top of the head. Palmitate solution was injected very slowly 
to prevent the animal going into convulsions. At various times 
after injection up to 24 hours, animals were sacrificed and the 
brains quickly excised and subfractionated according to the scheme 
outlined in section 2.2.1. 
WYROID HORMONE STUDIES 
Routinely, each litter used was divided into test and control pups. 
All. pups were given intra-peritoneal injections daily from birth 
according to their body weight. At various ages up to 20 days 
pups were sacrificed and their brains quickly removed and stored 
at -20 
0 C. B, lood samples were taken after decapi"tation and 
stored in heparinised tubes. The blood from control and test aninals 
at each age were pooled separately. Total plasma concentration was 
assayed by Dr. I. Broadhead in the Pharmacology Department, University 
of Sheffield. 
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2.2.9.1 Hyperthyroid studies: 
The test pups from each litter were given daily doses of 
thyroxine from birth. 0.01% thyroxine in physiological 
buffered saline (PBS) containing 0.02% sodium hydroxide, was 
administered in the ratio of O. Img/lOOgm body weight. 
Control pups viere injected with_PBS in the ratio of lml/lOOgm 
body weight. 
2.7.9.2 Hypothyrpid studies: Throuqhout the experiment 
. pregnant rats and lactating mothers were provided with drinking 
water containing n-propylthiouracil (PTU)(0.02% in tap water 
containing 0.02% NaOH) from the 13th day of pregnancy. At birth, 
. . -ome, - pups from each 
litter were given intraperitoneal injections 
of PTU dailyk? TO6ýhe solution used contained 0.5% PTU in PBS 
containing 0.02% NaOH and was injected into the pups in the ratic 
of lml/lOOgm body weight. The other pups were given PBS in 
the same volume/body weight ratio. (? Tv<, 
) 
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RESULTS 
3.1 DISTRIBUTION OF MARKER ENZYMES IN SUBCELLULAR FRACTIONS FROI'll 
. 
BRAIN TISSUE. 
3.1 .1 
In order to determine the subcellular location of the lipogenic 
enzymes investigated in this study, it was necessary to 
characterise the cellular components isolated in each of the 
fractions (F F. ) produced by the procedure outlined in section 
2.2.1. ý4arker enzymes were chosen as a suitable method of 
identifying the constituents of the various fractions. 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE (EC 1.1.49) 
The-activity of the enzyme glucose-6-phosphate dehydrogenase was 
used as a marker of the soluble fraction. In measuring the 
activity of fatty acid synthetase in all subcellular fractions 
it was important to assess the amount of enzyme activity that was 
due to contamination by soluble proteins. The results are 
shown in table 3.1. Most of the activity of glucose-6-phosphate 
dehydrogenase was associated with the supernatant fraction F0 4 
This is to be expected since the location of this enzyme is the 
cell cytoplasm. The activity associated with the particulate 
fractions (Fl, F F, ) may be due to cell cytoplasm both trapped in, 21 
and adhering to, membrane vesicles and organelles. Bourre et al 
have shown a similar -distribution of glucose-6-phosphate dehydrogenase 
in their subfractionation of mouse brain (181). 
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TABLE 3.1 
Distribution of marker enzymes in subcellular fractions of rabbit 
brain. 
Glucose-6-phosphate dehydrogenase was assayed as outlined in the 
methods in the total homooenate and subcellular fractions. Results 
are expressed in pmol/min ut: e per total fraction and % total activity 
and are mean t S. E.. of duplicate determinations of 3 separate samples. 
Malate dellydrogenase was assayed in sonicated fractions and the 
results are expressed as for glucos--, -6-.,, )hosphate dehydrogenase. 
(i) recovery of malate dehydrogenase activity from 'crude' F, fraction 
(ii) recovery of malate dehydrogenase activity following washing 'crude' 
F, fraction to give Fl. 
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3.1.2 HALATE DIEHYDROGENASE: NAD DEPENDANT (EC 1.1.37 
The distribution of the activ'-, ty of malate dehydrogencise was used 
to determine the localisation of mitoc'! -Iondria in the SUbcellular 
fractions obtained (table 3.1). Since the enzyme is found in the 
mitochondrial matrix, the activity measured in sonicated samples 
of the, particulate fraction F, - F3-(80 85%) is derived from 
whole mitochondria, whereas the activity in the cytoplasmic fraction 
F4 (10%). is a measure of mitochondrial rupture during the fraction-- 
ation procedure. 
Initially, the resuspended pellet obtained from the first 10,000gmin. 
centrifugation was used as the crude F, fraction. This fraction 
was also used in the determination of the subcellular location of 
palmitoyl-CoA synthetase (section 3.21-3) být was found to contain 
high levels of unitochondrial malate dehydrogenase. Repeated 
resuspension and centrifugation of crude F, at 8,000amin. gave rise 
to the F, fraction which shoas a much reduced malate dehydrogenase 
activity (5%). The longer F, preparation procedure'reduced the 
mitochondrial contamination, as ii,, easured by malate dehydrogenase 
activity from 32% of the total activity to 5%. 
4 Fraction F2, designated mitochondria-enriched fraction, n fact 
contains 79% of th e total marker enzyme activity. It is clear 
from table 3.1 that the crude F1 fraction contains an appreciable 
amount of mitochondrial material entrapped in it and that '%-. he 
washing procedure which gives rilse to fraction F, liberated much 
of the mitochondrial contamination. The distribution of micro- 
somal material throughout the subfractions will be discussed in 
section 3.2.3 when the subcellular location of palmitoyl-. CoA 
synthetase is considered. 
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3.2 THE ACTIVITIES OF LIPOGENIC ENVITS IN MAMMALIAN BRAIN TISSUE. 
The activities of the enzymes involved in the synthesis and further 
metabolism of fatty acids considered in this study are (1) fatty 
acid synthetase (2) acetyl-CoA carboxylase and (3) palmitoyl-CoA 
synthetase. 
- 
The results obtained from the assay of these 
enzymes in developing rat and rabbit brain will be presented in 
the following sections: 
3.2.1 FATTY ACID SYNTHETASý. 
3.2.1.1 Assay of Rabbit Brain Fatty Acid Synthetase. 
Acetyl -CoA dependent incorporation of 
14 C-malonyl-CoA into a 
cliloroform: niethanol (2: 1 v. v) soluble product by the cytoplasmic 
fraction (F4) from rabbit brain, 12 days post partum was linear 
with time for up to 10 minutes (see figure3.1). Figure 3.2 shows 
14 that the incorporation of C-malonyl-CoA was linear up to 2.2mg 
protein from the F4 fraction from a 12 day old rabbit. 
Thin layer chromatography of the chloroform : metha. nol extract 
on the chromatogram. Tile spot, from the assay gave only one spot 
detected by visualisation with iodine vapour and radio-thin layer 
scanning, had an Rf value of 0.55 equivalent to free fatty acid in 
the neutral lipid solvent (petroleum ether: diet-hylether-. acetic acid 
75: 25: 1 v/v). 
L. EI Gas-liquid radiochromatography of methyl esters of the ssay product 
showed (table 3.2) that the major fatty acid synthesized was 
palmitic C 16: 0 (79.8%) with smaller proportions of myristic C 14: 0 
(4.5"0') and stearate C'18: 0 (15.7%). The ratio of the radioactivity 
in the carboxyl carbon to the total radioactivity in the fatty acid 
chain_%,., as determined to distinguish between de novo synthesis and 
elongation. 
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FIGURE 3.1 
The activity of fatty acid synthetase from adult rabbit brain. 14 
The activity is plotted as nmol . C-malonyl-CoA incorporated 
into non-polar material per mg protein from fraction F4 in the 
standard assay against tire in minutes. Results are mean 
S. E of duplicate determinations of three different animals. 
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FIGURE 3.2 
The activity of fatty acid synthetase from adult rabbit brain. 14 
The activity is plotted as nmol . C-malonyl-CoA incorporated 
into lipid material per minute in the standard assay against 
nig protein from fraction F4. Results are mean ± S. E. of 
duplicate determinations of three separate brains. 
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The products of fatty acid synthetase. 
Values are expressed as %'radioactivity recovered in each fatty 
acid. Fatty acids %%, ere separated as their methylesters by gas- 
tography and radioactivity was determined by on line liquid chroma-01. 
radiogas proportional Minting. The values shown are the mean % 
of up to six determinations and were the products ol the experiments 
to determine age dependant changes in fatty acid synthetase activity 
sho, an in Figure 3.3. 
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The theoretical value of de novo synthesis of palmitic acid from 
14 C labelled malonyl-CoA is 12%. The result obtained, 11 t 2% 
(6 det. ) is in good agreement with this value. Elongation of a 
precursor fatty acid molecule would give rise to a value larger 
than this depending upon the size of the fatty acid cha-in. 
3.2-1-2 Subcellular localisation of Fatty Acid Synthetase: 
Fatty acid sypthetase from all mammalian tissues studied is a 
soluble protein complex. Rabbit brain tissue is no excep-tion to 
this statement. Table 3.3 shows the distribution of fatty acid synthet-ase 
in rabbit brain subfractions. The majority of the enzyme activity 
recovered was detected (97%) in the F4 fraction which contains the 
cytoplasmic enzymes. This is in agreement', with other workers (68,112). 
Aeberhard and Menkes (150) showed that de novo- synthesis of palmitic 
acid takes place in particulate fractions in the absence of ATP, but 
the activity recovered from the soluble fraction was several fold 
higher than microsomal and mitochonýrial enzyme activities. The 
high total activity of the crude homogenate of rabbit brain, may be 
due, in part, to the elongation of endogenous medium and long-chain 
fatty acids as well as de novo fatty acid syn-Ithesis. The synthetic 
activity seen in the absence of HADPH and acettyl-CoA may be due to 
the presence of these endogenous substrates in the crude homogenate 
fraction. 
2.1.3 Changes in the Activity of Fatty Acid Synthetase. durine development: L ý. 
Changes in the activity of rabbit brain cytoplasmic fatty acid 
synthetase are shown in figures 3.3 and 3.4. 
Results are expressed as 
- a-- activity per ing protein in the soluble fraction 
(F 4) 
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TABLE 3.3. 
Recovery of fatty acid synthetase from all fractions prepared from 
10. day old rabbit brain. 
Results are expressed as nmol mal onyl-CoA incorporated into lipid 
per mg protein per minute and are mean ± S. E. of four separate 
determinations. Total activity is expressed as nmol malonyl-CoA 
incorporated per minute per fraction. 'The standard assay was used 
in all cases except where either NADPH or acetyl-CoA were absent. 2 
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There was a steep rise in the specific activity of fatty acid 
synthetase (Figure. 3.3a) during the last third of gestation to- a peak 
at. 5 days of age. The maximum specific activity at 5 days of age 
was 1.2 nniol malonyl-CoA incorporated/mg protein/minute. This 
was followe. d by a progressive decline to 35 days of age, where the 
specific activity was 0.43 nmol. /nig/minute and not significantly 
different from the value obtained for the adult rabbit brain. 
The total fatty acid synthetase activity of the whole brain (Figure 3.3b) 
reached a maximum at 15 days of age and then fell only slightly to the 
adult value of 48.6 nmol /whole brain/minute. When the activity 
of brain fatty acid synthetase is expressed per mg DNA (Figure 3.4a) 
a sharp rise is seen to a peak activity of 8.6 nmolz malonyl-CoA 
incorporated/mg DNA/minute followed by a rapid decline to the adult 
value of 3.6 nmol malonyl-CoA incorpo , rated/mg DNA/minute. The 
activity per gram viet weight of tissuei,,, as very similar to that seen 
per mg DNA although initially there was a fall in activity from 21 
days gestation to 27 days gestation (Figure 3.4b). 
I. 
The peak specific activity of fatty acid synthetase occurred at 5 days 
of age which is before the period of maximum myelin synthesis of 
10 - 25 days after birth (4). This apparent early maximum may 
only be due to the use of protein concentration as a parameter for 
enzyme activity, since, during the early post-natal period, there 
is a rapid increase in cell number and, although the total, affiount 
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FIGURES 3.3 AND 3.4: 
Acitivty of rabbit brain fatty acid synthetase. 
The enzymes was assayed in the soluble F4 fraction o, developing 
rabbit brain using the standard assay. Duplicate incubations 
for 5 and 10 minutes were carried out. Activity iý., as determined 
as nmol malonyl-CoA incorporated. into lipid per minute and sholan 
as 3.3(a) incorporation per mg protein per minute and 3.3(b) 
incorporation per brain per minute. 
Figure 3.4(a) shows incorporation per mg LIX-NA per minute and 3.4(b) 
incorporation per 9m wet weight of tissue. 
All values are the mean. All determinations and S. E. values 
are shown where three or more animals or groups of animals were 
used. Age is shown in-days from 21 days gestation (do) to adult. 
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of fatty acid synthetase protein may be increasing during this 
period, this fact is hidden by a larger increase in the amount 
of other proteins. Expressing the results in terms of DINA may 
give a more realistic picture of the changes in enzyme activity 
taking place during cell multiplication. Because the DNA content 
of each cell is constant, changes in the total amount of DNA in 
brain reflect changes in cell number. Therefore, enzyme activity 
expressed per mg DNA will. give an indication of cellular changes in 
enzyme activity. The activity of fatty acid synthetase, when 
expressed per DNA (Figure 3.4a) showed peak activity at 15 days 
postnatal which is during the period of maximum myelin formation. 
Expressing the data as incorporation per brain also showed maximum 
enzyme activity at 15 days of age, but this vas not followed by a 
steep decline in activity', sKowing that fatty acid synthetase was 
still very active in the. adult animal. Results eXpressed per 
gram fresh tissue also indicated* thýt-, -maximum enzyme adtivity was at 
15 days. 
The development pattern of rat brain fatty acid synthetase was 
similar to that from rabbit brain (Figures 3.5,3.6 
The maximum incorporation of 
6lonyl-CoA per mg protein into fatty 
acid occuraiat 5 days of age whereas the data expressed per mg VIA, 
per gram fresh tiss . ue and per whole brain, showed maximum activity 
at 13 days of age. Expressed per gram fresh tissue (Figure 3.6b) 
the activity of brain fatty acid s ynthetase in the newborn rat %,, as the 
same as in the adult rat, although between 5 and 19 days of age the 
activity doubled to give a peak value of 24.3 nmol P. ialonyl-CoA 
incorporated/gram fresh tissue/minute at 13 days after birth. 
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FIGURES 3.5 and 3.6 
Theactivity of rat brain fatty acid synthetase. 
The enzyme was assayed in the soluble F4 fraction of developing 
rat brain using the standar6 assay. Incubations were carried 
out for 5 and 10 minutes in duplicate. Activity was determined 
as nmol malonyl-CoA incorporated into lipid per minute and 
expressed as 3.5 (a) per mg protein per minute 3.5 (b) per whole 
brain per minute, 3.6 (a) per mg DNA per minute and 3.6 (b) per 
gm wet weight of tissue., All values are the ri-ýean of all 
determinations and S. E. values are shown where three or more 
animals were used. Age is shown in days. 
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q. 2. ACETYL-CoA CARBOXYLASE 
Acetyl-CoA carboxylase activity detected in the developing 
rabbit brain was very low. See Table. 3.4 . Pre-incubation 
of the sample with citrate did not give any appreciable increase 
in activity. The rate of bicarbonate incorporation into acid 
soluble material in the absence of. acetyl-CoA accounted for 6011) of 
the total rate in the crude homogenate of 12 day rabbit brain and 
51010' in the crude homogenate of 18 day rabbit brain. In the F4 
fraction the rate of bicarbonate incorporation in the absence of 
acetyl-CoA was 57% of the activity measured using the full assay 
mixture in an 18 day rabbit brain. Although a G-25 sephadex 
column was used to separate protein from smaller molecular species 
in order to remove any inhibitors of acetyl-CoA carboxylase that 
may have been the cause of the low activities shown in Table 3.4 
no change in activity was seen. 
The enzyme was also assayed by measuring the incorporati. on of 
14 
acetyl-CoA into lipid material. 14ADPH and C-acetyl-CoA and 
unlabelled sodium bicarbonate were used in the standard acetyl- 
CoA carboxylase assay. The result obtained using a rat liver F4 
preparation was 1.03 nmol /mg protein/minute. This valUe agrees 
closely with the result of 1.4 n9lol /mg protein/minute using the 
incorporation of H 
14 C03- into malonyl-CoA ( 178 
The rat brain enzyme has been investigated by Gross and Warshaw ( 113) 
who showed that its specific activity was 3.0 nmol /ng protein/minute 
in the supernatant fraction of foetal brain. The specific activity 
rose slightly to a maximum of 3.4 nmol /mg protein/minutte at 14 
days of age and then after an initial steep decline fell slowly to 
the adult value which was 55% of that obtained during the early 
postnatal period. 67, 
TABLE 3.4 
Activity of Acetyl-CoA carboxylase. 
Results are expressed as nmol HC03- incorporated into acid soluble 
matOria. 1 per mg protein per minute. The standard assay was used 
in all' casles except 0-here specific omissions are recorded. 
Experiments with radiolabelled acet.,,,, l-CoA were carried out in the 
standard assay mixture plus NADPHI, and activity was determined as 
radioactivity extracted in lipid per mg protein per minute. All 
values are the means of duplicate determinations carried out for 
5 and 10 minutes. 
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The activity of the rabbit brain enzyme, measured under the 
3.2.3 
3.2-3.1 
same conditions, was -100 fold lower. 
The specific activity of rabbit brain acetyl-Col'i carbo, -,, ylase, 
in the crude homogenate was 70% lower at IS days than at 12 days; 
a smaller fall in activity was shown-by the rat brain enzyme ( 113). 
A decrease in the activity of both rat and rabbit brain fatty acid 
synthetase was also seen at this time. 
Although variations in substrate concentration did not lead to a 
higher specific activity, rabbit brain acetyl-CoA carboxylase may 
differ from the rat brain enzyme in its requirements for activator 
and substrate molecules. 
PALMITOYL-CoA SYNTHETASE 
This enzyme was studied since it is intimately involved in the 
further metabolism of both the products of fatty acid synthet -ase and 
free fatty acids taken tip by the brain, because only the CoA 
derivative of fatty acids are further metabolised. Pal. mitoyl-CoA 
synthetase iý, las assayed in all subfractions using a linked assay 
involving acyl-CoA carnitine acyl transferase. Optimum conditions 
for the assay of acyl-CoA synthetase were determined before studying 
changes in palmitoyl. -CoA synthetase activity Ouring development. 
Assay of Acyl-CoA carnitine acyl transferase from bovine and calf 
liver: 
This assay is based upon tile reversiblljty of the reaction 
palmitoyl-carnitine A- CoA -- palpiitoyl-CoA + carnitine 
3_3 
arnitine + CoA palmitoyl-CoA + H-carni tine-----" palnlitoyl H cL 
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By determining the amount of palmitoyl_3 H-carnitine formed per 
minute, a measure of the activity of the carnitine acyl transferase 
will be obtained. However, the amount of palmi toyl_3 H-carnitine 
formed per minute in this assay is not a direct measure of the 
ability of this enzyme to convert palmitoyl-CoA to palmitoyl- 
3ji_ 
carnitinein the linked assay system. The amount of palmitoyl-CoA 
carnitine acyl transferase required to saturate the linked assay 
system was determined empirically with each carnitine acyl transferase 
preparation. 
ýS44. 
'---I III 
) 
The formation of palmitoyl_3H-carnitine in the exchange reaction 
was found to be linear with time up to 45 minutes (Figure 3.7 
and with protein up to 1. Omg of enzyme preparation. Routinely 
however,. 0.2 - 0.5 mg of protein was sufficient for the acyl-CoA 
synthetase assay. 
3.2.3.2 As-say-o-I Palmitoyl CoA Synthetase: 
The linked assay with carnitine acyl transferase was found to be 
linear with up to 3.0 mg- of protein - from the crude homogenate 
of rabbit brain (Figure 3.8a). The formation of palmitoyl carnitine 
was linear for up to 12 minutes us-Ing 0.1 mg of protein from the 
F3 subfraction of adult rat brain (Figure 3.8b). The conditions 
used for the assay. of palmitoyl-CoA synthetase were constant for 
the assay of material from both rat and rabbit brain. 
3.2.3.3 Subcellular location of Palmitoyl-CoA synthetase: 
The subcellular location of this enzyme has been described by other 
workers as microsomal and mitochondrial. 
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FIGURE 3.7 
The activity of carnitine acyl transferase prepared from calf and 
bovine liver. 
(a) Time-dependant labelled ac: yl-carnitine formation was measured 
using the standard assay containing 0.25mg protein. Points sho-vin 
are mean ý S. E. of determinations in duplicate over a period of 10 
days. 
(b) palm i toyl-carni tine formation was measured with increasing 
protein concentration in the standard assay system incubated for 
10 minutes. All points shown are the mean ý S. E. of duplicate 
determinations of activity in three different enzyme preparations 
from bovine liver mitochondria. 
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The activity of rabbitt: brain palnitoyl-CoA synthetase. 
Palmi-Loyl-CoA syn-(-Ihe-tase activity was determined using the linked- 
enzyme assay as palmitoyl-carnitine extracted from the standard assay 
mixture. (a) Palmitoyl-CoA synthetase activity as a function of 
protein from the crude homogenate of 17 day old rabbit brains. All 
points are the mean ± S. E. of results obtained in assays for 5 and 
10 minutes carried out on hom. ogenates from different animals. 
(b) The time-dependant formation of palmi toyl-carpi tine was measured 
in duplicate assays containing O. lri. g of protein from the microsowal 
(F 3) fraction. All points are mean 
t S. E. of six doterminations. 
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Ho, wever, as seen in Table 3.5a, activity could be detected in 
all subfractions obtained from adult rat brain prepared according 
to the method outlined in section 2.2.1. The study of 
developmental changes in palmitoyl-CoA synthetase activity described in 
section 3.2.3.4 was carried out using a fractionation schemna, v,, hich 
omitted viashi. ng the crude F, fracti-on. This method was modified 
in an attempt to decrease the large discrepency between tile palmitoyl- 
CoA synthetase activity in the whole hoi,.,, ogenate and that recovered 
in the mitochondrial and microsomal fractions. Table 3.5b shows 
the effect of washing tile crude F, fraction according to the 
fractionation scheme. Although by. -Ilhis three step procedure 
the total amount of protein in the supernatants %,., as only 17.6% of 
that present in the crude F, fraction, the acyl-CoA synthetase 
activity released was 47% of total activity of tile crtide F, fraction. 
This indicated that there was a large qUantity of material . trapped 
in the membranous F, fraction. 
The recovery of palmitoyl-CoA synthetase activity from all the V 
fractions(Table 3.5a) was 98%. The soluble fraction (F4) and the 
membranous F, frqction, account, for more than 40% of this activity. 
An attempt to identi I the activity associated with fraction F, by 
continuous density gradient centrifugation will be discussed in 
section 30.3.5. Actjvi V in the cytoplasmic fraction F may 4 
be caused by smalf"Mcrosomal vesicles that were not sedimented in 
the preparation of the microsomal frac-Lion (F3). The fracLion 
with the highest activity (37, o) was fraction F2 1'1'1'cý' also contained 
the highest activity of malate dehydrogenase (491io see Table 3.1 ) and 
was shoi.., n by Gray & Whittacker (33) to contain a high proportion of 
of mitochondria. By contrast, this fraction only contained 12.5'/13 
the total protein giving an enzyme activity: protein ratio of 0.5. 
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TABLE 3.5 
The activity of palm. itoyl-CoA synthetase in subcellular fractions 
of adult rat brain. 
Results are mean ý S. E. of four separate fractionations. All 
activities (nnol palmitoyl-carnitine/fraction) are the result of 
duplic ate determinations carried out for 5 and 10 minutes using 
the standard assay and then corrected to give total activity per 
fraction. Protein deteriminations were carried out in duplicate. 
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TABLE 3.5 b 
The effect of washing the crude F, fraction from adult rat brain. 
Palmitoyl-CoA synthetase activity is expressed as nmol palmitoyl- 
carnitine formed per fraction per minute using the standard assay. 
All total activities are the result of duplicate determinations 
carried out for 5 and 10 minutes using the standard assay. Each 
value is the mean ý S. E. of four separate fractionations. 
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The microsomal fraction E3 contains an even higher concentration 
of enzyme activity giving an activity : protein ratio of 1.6. 
Changes in Palmitoyl-CoA synthetase activity during development. 
The data presented in this section was obtained using fractions 
F2 and F3 prepared directly from the supernatant obtained in the 
preparation of the 'crude' F1 fraction Although the 'crude' Fl 
fraction prepared from adult brain is heavily contaminated with 
mitochondrial and microsomal material (sections 3.2.3.3 and 3.2.3.5) 
this data was not corrected for contamination since animals of 
different ages were used. 
The specific activity of palmitoyl-CoA synthetase in the crude 
homogenate of rabbit brain was approximately 0.8 nmol/mg 
homogenate protein per minute throughout development. (Figure 3.9a) 
The highest specific activity of palmitoyl-CoA synthetase, in the 
rabbit brain mitochondrial fraction F, (Figure 3.9b ) was in the 
late foetal and early neonatal period. The specific activity 
declined to a value similar to that of the adult brain.. 0.55 nrr,, ol/ 
min per mg. protein, by twelve days of age. In contrast, the 
specific activity of the enzyme in the rabbit brain microsomal 
fraction (F3) increased from the late foetal period to reach a 
maximum at 15-20 days of age. The maximum activity of 5 nmol/ 
mg per minute was a. three-fold increase from the activity at birth. 
From twenty days the specific activity of the enzyme declined to 
the adult value, which was about half the maximum specific activity 
(Figure 3.9b ). 
The specitic activity of the microsomal enzyme was 
twice that of the 
mitochondrial enzyme at birth and ten 
times higher between 15 and 20 
days of age. 
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Changes in the specific activity of pa"Imitoyl-CoA synthetase in 
rabbit brain during development. 
-e Activity is expressed as nmol palmitoyl-CoA syn-thesised/minu'L 
per mg protein in (a) the full homogenate ) and (b) the 
microsomal F3 ( M-M ) and mitochondria-enriched (F2) fractions 
( *-x ). Each point is the mean value 
t S. E. from at least 
four groups of animals. The foetal. age is shoan as days 
gestation (dg). 
> 
ro 
(L) 
LA 
-C c >1 
0 
>1 0 
E 
fo a 
C: 
fo 
-0 
SO 
C: 
M 
a) 
0) 
C: 
C) 
(Y) 
a) 
cn 
E 
e--% - -- 
. 
-0 
Co (6 
Liigloid ßw jgd UIW/Pwu 
0-4 
-0 
(li 
CD 
-0 
w 
c: > (D 
01 
-0 
(Tj 
C3 
CY) 
-0 
LLI 
C14 
LD CD in 
V--.: V--: C3 
uo-joid 5-u jad -ui. w/lowu 
These changes in specific activity %,., ere not seer, in the cell-free 
homogenate results be-cause of the large increase in brain total 
protein taking place during this period. The wide variation in 
enzyme activity may be due to a greater variation in the amount of 
protein used in assays of this fraction than in incubations containing 
microsomal or mitochondrial protein. 
I 
The whole brain activity of palmitoyl-CoA synthetase rose steeply 
from bir-Lh to' adult valueS LISing the cell-free homogenate of rabbit 
brain (Figure 3.10). The mitochondrial (F2) and microsomal (F 3 
fractions obtained from the supernatant of the 'crude' F, fraction 
accounted for only 40% of the total whole brain activity at birth and 
10%- in the adult brain. Therefore 60-90% of the enzyme must be 
either trapped or located in the crude. F, fraction. Since 80% 
of the total activity of the rat brain enzyme is trapped in the 
crude F, fraction (Table 3 .5) 
it is not unreasonable to concluete 
that a similar amount must be trapped in the 'crude' F, fraction of 
rabbit brain. 
In order to test this hypothesis, the 'crude' F1 fraction was washed 
three times as outlined in section 2.2-1. The resultant fractions, 
Fl, F2, and the washings, were further analyzed byrate-zonal density 
, ent centrifugation, and the subfractions obtained were assayed grad 4 
for palmitoyl-CoA synthetase activity. 
Distribution of Palmitoyl-CoA Synthetase in Fractions F, and F2 in rat brain 
after Density Gradient Centri"I'Llgatlon. 
Figure 3.11 is a visual representation of the pattern of bands obtained 
after sucrose density gradient centrifugation of the membrane fraction 
(Fl) the mitochondrial fraction Q) and the pooled supernatants (S) 
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Changes in the whole brain activity of palmitoyl-CoA synthetase 
in rabbit brain during development. 
Activity is expressed as nmol palmitoyl-CoA synthesized/minute 
per total fraction for the full homogenate the mito- 
chondria-enriched fraction (F2) (MI-1g) and the microsomal (F., ) 
fraction (0---o). Each point is calculated from the mean values 
presented in Figure 3.9,. 
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obtained by washing the 'crude' F, fraction. In general, 
subjecting the fractions to hypotonic lysis caused a di. splace- 
ment of the bands down the gradient and a subsequent broadening. 
Palmitoyl-CoA synthetase activity was found in bands 1-3 on the 
gradients. The position of band 1 was equivalent to that 
occupied by %.., ashed material from the microsomal fraction (F3). 
Purified myelin, prepared by the method of Autilio ( 43 ) gave 
a band in the region of 0.7-0.8 M sucrose which was in the same 
position as band 2. Material from band 3 (0.9 1-1 sucrose) was 
found to be high in malate dehydrogenase activity and therefore 
of mitochondrial origin. 
The effect of osmotic shock on all fractions applied to density 
gradients was to cause a lowering of the palmitoyl-CoA synthetase 
activity in band 2, the myelin fraction, and an increase in the 
enzyme activity found in bands 1 and 3. This indicates that 
mitochondrial and microsomal material was trapped in the myelin 
fraction (band 2). The origin of band 4 (1.1 M sucrose) obtained 
by gradient centrifugation of F, material after hypotonic lysis is 
unknown, but a similar band was obtained after freezing the crude 
membrane fraction (F, ) during the isolation of radio labelled 
material following intracranial injection of 
3 H-palmitate. Since 
this band has no acyl-CoA synthetase activity, it probably Js 
composed of large aggregations of myelin membrane. 
From the above results it appears that the fraction F, contains 
an appreciable amount of mitochondrial and microsomal material which 
contributed up to 60% of the palmitoyl-CoA synthetase activity 
measured in that fraction (Figure 3.11 ). 
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FIGURE 3.11 
Distribution of palmitoyl-CoA synthetase activity folloviing density 
gradient centrifugation oil fractions from adult rat brain. 
Fractions F, and F2 were prepared as in section 2.2.1 and Fraction S 
were the pooled supernatant fractions from washing the 'crude' F 
fraction. All fractions A were control and all fractions B were 
the result of hypotonic lysis. Gradients were formed in a linear 
fashion from 0.511 to 1.5111 sucrose buffered at pH 6.8 with 0.25111 
C, 
potassium phosphate and centrifuged at 9x 10 amin. Palmitoyl- 
CoA synthetase was determined using the standard assay and the 
activities shown are typical for % distribution. 
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The recovery of palmitoyl-CoA synthetase activity from the 
gradients was between 40 and 50% (Table 3.6 ) whereas the 
recovery of protein was between 40 and 70%. The apparent 
low recovery of protein from gradients containing material 
from the F, fraction may be due to the presence of large quantil. Jes 
of lipid in this fraction. The increase in palmitoyl-CoA synthetase 
activity seen in Band 1 following hypotonic lysis of all three . 
fractions may be derived fromeither microsomal material thatwas 
occlude in I'arge membrane vesicles or mitochondrial membranles formed 
by intact mitochondria rupturing. 
Fraction S, obtained by pooling the supernatants when washing the 
'crude' F, fraction, had a similar band pattern to the mitochondria- 
enriched fraction (F2) (Figure 3.11). There was some palmitoyl-CoA 
synthetase activity associated with the microsornal band (1) before 
osmotic shock and. this could represent microsomal material washed 
from the 'crude' F, fraction. The enzyme activity in the myelin 
band (2) was decreased by osmotic shock and there was a concomitant 
- mi to- -h bands 1 and 3 indicating tha-ft. increase in activity in boll, 
chondrial and microsomal material was trapped in the myelin fraction. 
The results presented in this section show that the brain fractions 
prepared as in section 2.2.1 were not homogeneous and the re was a 
degree of contamination of each fraction by mitochondrial and micro- 
somal material. From the data in Table 3.6 75%' of the palmitoyl- 
CoA synthetase activity in the membrane fraction F, was associated 
with microsomal and mitochondrial material. 
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TARH: IA 
Activity of palmitoyl-CoA synthetase in subfractions of adult rat 
brain obtained by-density gradient centrifugation. 
All values are mean ± S. E. of at least four separate determinations 
using duplicate 5 and 10 minute assays. The nomenclature for 
fractions and bands is the same as in Figure 3.11. 
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Removal of band 2, rehomogenisation and density gradient 
fractionation only lead to a broadening of the myelin band, no 
change was seen in the distribution of enzyme activity. inF, and F2 
The mitochondria-enriched fraction (F2) however, only contained 
8% microsomal contamination as measured by palmitoyl-CoA synthetase 
activity in band 1. 
The Distribution of Palmitoyl-CoA Synthetase Activity in the 
Microsomal Membrane Fraction ( 3) of Mature Rabbit Brain. 
Because the microsomal fraction contains membrane vesicles from a 
number of different cell types, sucrose density gradient fractionation 
was used to separate this material according to its buoyant density 
in order to determine the distribution of palmitoyl-CoA synthetase 
in this fraction. 0.5-1.0 mg of microsomal protein, prepared as 
outlined in section2.2.1 were loaded onto 12 ml continuous sucrose 
density gradients. The sucrose gradient, buffered with 0.25 f,, l phosphate 
pH 7.5, was 0.25-1.25 M. After centrifugation at 40,000xg for six hours 
--each. gradient was unloaded and each fraction was read at 260nm 
to give the protein distribution shown in Figure 3-. 12a. 
The distribUtion of palmitoyl-CoA synthetase activity is shown in 
Figure 3.12b. jwo peaks of activity were detected in fract '-i ons 
4-7 and 11-13 respectively. The relationship of this activity with 
the incorporation of malonyl-CoA into fatty acids in the microsomal 
fraction will be discussed in a later section. 
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Sucrose density gradient centrifugation of washed microsomes from 
adult rabbit brain. Iml fractions were collected by unloading 
from the bottom therefore fraction I is at the bottom of the 
gradient and fraction 13 is at the top. (a) protein content was 
measured as E 260 during unloading. (b) palmitoyl-CoA synthetase 
activity was determined in duplicate using the standard assay and 
is eXpressed as nmol palmitoyl-CoA synthesized/hour per fraction. 
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THE EFFECT OF THYROID HORMONE ANID PROPYLTHIOURACIL ON THE 
DEVELOPINU RAT BRAIN.. 
Thyroid horwone has been implicated in the normal maturation of 
the brain. Although it was shot-in to have no effect upon fatty 
acid synthetase 112 there viere no data available for its 
effect on the palmitoyl-CoA synthetase systems in subf)-actions from 
the developing brain. Therefore the results presented in the 
follot-iing section are from an investigation. into this area of 
potential hoýmonal control. 
Thyroid Hormone, Propylthiouracil and Normal Brain Developmept.. 
Rats given thyroxine were morphologically and behaviourally more 
advanced than the littermate controls, whereas thogn-, given propyl- 
thiouracil were retarded with respect to the control rats. Eye- 
opening, hair formation and the unfolding of the pinna of the ear, 
were all advanced. in the animals given thyroxine. 7hese rats were 
also more physically active. Conversely, the rats given propyl- 
thiouracil were behaviourallv and morphologically retarded by one V 
or tw-o days. 
Fron, four days of age, the weight of Ihe brains 1rom thyroxine-- 
treated rats %-, as consistently loý..,? ear than the average weight of t. he 
brains of the sal i neý-injected litter -. na-ILe controls (Figure 3.13a). 
Although there was no difference between the weights Of the brains 
Of the ra-ILs given propylthiouracil via the maternal circulation 
the brains from rats while in utero (group PTUa) and the weight of t. I 
receiving daily doses of propylthiouracil until they were sacrificed 
(group PTUb)(Figure 3.13b these brains were aiso of lo; der weight 
than the saline-injected littermates. 
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The effect of thyroxine and propylthiouracil on the weight of the 
developing rat brain. 
(a) the effect of thyroxin-- administration on brain weight increase. 
Values are for the average brain weight from a single litter. - 
thyroxine adminisit-Tation 40 saline-injected 
controls. (b) the effect of maternally ingested propylthiouracil (PTUa) 
and daily injections of propylthiouracil (PTUb) on the increase in brain 
weight. All values are the mean for the litters 
ff PTUa 0 PTUb 
N. B: 
Figures 3.13 and 3.14, Tables 3.7 and 3.8: 
In the study of the effect of hormones on the developing rat brain the 
values presented are the mean 1 either difference from the mean or 
standard eI rror depending on the number of litters used. Below are the 
numbers of litters used in this study for saline-injected controls, 
thyroxine treatment and propylthiouracil treatment. 
(PTUa - maternally ingested propylthiouracil; PTUb - daily injection of 
propylthiouracil) 
Age in days Control Thyroxine PTUa PTUb 
1 2 2 
4 4 4 1 1 
7 2 2 1 
8 
9 
10 1 1 1 1 
13 - - 2 2 
14 3 3 - - 
15 1 1 3 3 
16 - - 2 2 
18 3 3 
20 1 1 
Figure 313 The effect of thyroxine and propyl- 
thiouracil on brain weight. 
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FTPIlPF I 1A 
The effect of thyroxine and propylthiouracil on the body weight of 
the developing rat. 
(a) the effect of thyroxine administration on body weigh-It. Values 
are the mean of all the animals in t-io litters. thyroxine 
0-0 saline-injected controls. 
(b)-the elfect of maternally ingested propylthiouracil (PTUa) and 
daily administration of propylthiOUracil (PTUb) on body weight. 
Values are the mean of all the animals in the litters. 4i--i-lu PTUa 
01-0 PTUb. 
Figure 3.14 The effect of thyroxine and propyt- 
thiouracil on body weight. 
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TABLE 3.7 
The effect of hormone treatment on the level of rat brain DNA. 
Values are sho-an in mg DNA per brain for controi rats, thyroxine- 
injected and those receiving propylthiouracIl via the maternal 
circulation (PTUa) and receiving daily doses of propylthiouracill 
by injection (PTUb). All values are expressed as outlined for Fig. 
3.13. 
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TABLE 3.8 
The effect of hormone treatment on plasma Iodine levels. 
All values represent plasma iodine concentrations in pooled sera 
from each litter and are expressed as outlined for Figure 3.13. 
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The weights of the brains from both the thyroxine-injected and 
propyl, thiouracil-injec-ted grOLIPS of rats were very similar. 
Similar results were obtained plotting body weight against age. 
The control rats had higher body weights than the littermate 
test animals. There was little difference in body weight 
between the thyroxine and propylthiouracill-injected rats (Figures--. 
3.14a and 3.14b). 
There was little difference seen in tile DNA content of whole brains 
from test and control rats at all ages (Table 3.7 ). Since 
different regions of the brain increase in both weight and cell 
number at different rates during development, changes in whole 
brain DNA will only give an overall picture of brain cell multiplication. 
The total plasma iodine concentration, shown in Table 3.8 in the 
rats given thyroxine was higher than that of the control group of 
al 1 ages. In both groups. of rats receiving propylth-jouracil, the 
plasma iodine concentration was lower than the control value. Tile 
. _, 
reason for the lower values from group PTUa compared with group PTUb 
is not clear. 
Figures 3.15 and 3.16 shovi the amoun't. of protein recovered from, 
the cell-free homopenate (CF11) and the fractions F, - F4 with 
increasing ages. In general, except in the cell-free hornogenate, 
fractions obtained from rats given thyroxine had a higher protein 
content than control rats at all ages studied. The protein content 
of fractions F, - F3 from both groups of rats given propylthiouractl 
(PTUa and PTUb) was lower than that of the control rats. 
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The effect of hormone treatment on the protein content of rat brain 
homogenates and subfractions. 
Control thyroxi ne- injected propylthiouracil via 
maternal circulation (PTUa)( ") and propylthiouracil via daily 
injection (PTUb) ( 0ý ). All vIlues are expressed in mg per 
brain or mg per fraction and are the mean of duplicate determinations. 
(a) protein content of the full homogenate plotted against age in 
days. (b) protein content of the membrane fraction (Fl) plotted 
against age in days. 
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FIGURE 3.16 
The effect of hormone treatment on the protein content of rat brain 
s. ubf racti ons. 
Control ( 0-0 ) thyroxine-injected (&0) PTUa and 
PTUb All values are expressed in mg per fractioni and are 
the rilean of duplicate determinal. -ions. 
(a) Protein content of the mitochondria-enriched fraction (F 2) 
plotted against age in days. 
(b) protein content of the microsonal fraction (F3) plotted 
against age in days. 
(c) protein content of the soluble (F4) fraction plotted against 
age in days. 
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3.3.2. The Effect of Thyroxine and Propylthiouracil on the activity of 
Rat Brain Palmitoyl-CoA Synthetase. 
Palmitoyl-CoA synthetase activity was assayed in the crude homogenate 
washed 
and the membrane (Fl) mitochondria-enriched (F ) and the microsomal (F 2) 3) 
'fractions prepared as outlined in section 2.2.1. 
Because of the'small brain size-, the brains from either the test or 
control pups from each litter were homogenised together to provide 
enoughl material for the enzyme assays. Where t,. io or more litters 
were sacrificed at the sarrie age-, the enzymie activities iiere determined 
separately and the values obtained have been. expressed as in the 
previous section. Age dependent changes in palmitoyl-CoA synthetase 
activity have been expressed in the following ways : 
Sped fic acti vi ty ' (Fig. 3.117a-d) 
palmitclyl-CoA synthetase activity/mal DNA (Fig. 3.18a-d) 
palmitoyl-. CoA synthetase activity per brain.. (Fig. 3.19a-d) 
There was a 
.: 
ýV. ght _ý decrea§e in palmitoyl-CoA synthetase 
activity/mg protein from 0.2 to 0.1 nmol/mg per minute in the cell-free 
homogenate with increasing age in all groups of rats (Figure 3.17a) but 
no similar trend was apparent in the enzyme activity recovered fro-11 the 
subcellular fractions. Only the mitochondria-enriched fraction (F2) 
shoued any clear difference in palr. litoyl-CoA synthetase activity 
between control -rats and those receiving hormonal treatment. The activity 
of the enzyme in fraction F2 prepared fron the brains of rats receiving 
propylthiouracil was 6-fold lovier (0.5 nmol/mq per min) than the 
activity in the same fraction from control rats (3.0 namol/mg per min) 
and only slightly lo,. -jer than that recovered from rats receiving 
thyroxine (Fig. 3.17c). 
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FIGURE 3.17 
Activity of palmitoyl-CoA synthetase in subfractions of brain tissue 
following hormone treatment. 
Activity was measured as palmitpyl-CoA synthesized using the standard 
assay and all points are the mean of duplicate determinations carried 
out for 5 and 10 minutes. The activity of palmitoyl-CoA synthetase 
is expressed as ninol palmitoyl-CoA syn'thesized/mg protein per minute 
in (a) the full hoimogenate (b) the membrane fraction (F, ) (c) the 
2) and (d) the microsomal fraction mitochondria-enriched fraction (F 1 
-rol F 3* All values are expressed as outlined lor Figure 3.13. Cont 
thyroxine (c>--o) PTUa and PTUb (-D .... ). 
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Activity of palnitoyl-CoA synthetase in subfractions of brain tissue 
f-ollo, wing hori-imne treatment. 
Activity was measured as palmitoyl-CoA synthesized using the standard 
assay and all points are the mean of duplicate determinations carried 
o- for 15 and 10 m4 ut I nutes. The activity of palr-iitoyl-CoA synthetase 
is expressed as nmol palmitoyl-CoA synthesized/mg MIA per minute, in 
(a) the full homogenate (b) the membrane fraction. (Fl) (c) the 
mitochondria-enriched fraction (F L 2) and (d) the ti-dcrosomal fraction 
F 3* All values are expressed as outlined for Figure 3.13. Control 
thyroxine 11,0--0) PTUa and PTUb 
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There was no change with age in the homogonate activity of palmiitoyl- 
CoA synthetase (4,0 nniol/mg UIA per min) when expressed pet, mg DNA 
(Figure 3.18a ). Again, the only apparent differences caused by 
the various treatments were seen in the mitochondria-enriched fraction 
(F2) The enzyme activity in this fraction froni control and thyroxine 
treated rats rose steeply with age (1.0 - 9.0 nmol/mg DNA per minute) 
whereas there was little change in the activity measured in the propyl- 
thi ouraci 1 -treated rats (I. Onmol/nig DNA per minUte) (Fig. 318c). 
Expressing the data in terms of total activity per fraction per brain 
(Figures 3.19a -d) the palmitoyl-CoA synthetase activity in the 
homogenate increased with increasing age (4.0 - 12.0 nmol/brain per min. ). 
Thyroxine and propylthiouracil had no effect on the activity of the 
enzyme in the membrane (FI) and microsomal (F3) fractions, but again the 
F2 fraction from, the thyroxi ne- treated and control rats sfwvied a steep 
increase in activity (2.0 - 28.0 nmol/brain per minute). The same 
fraction recovered from propyl thi ouraci I -treated rats, showed no change 
and had a very lovi enzyme activity (2.0 nmol/brain per minute', 
(FigUre 3.19c). 
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FIGURE 3.19 
Activity of palrilitoyl-CoA synthetase in subfractions of brain tissue 
following hormone treatril. ent. 
Activity was measured as Oalmitoyl-CoA syn-tChesized using the standard 
assay and all points are the mean of duplicate determinations carried 
out for 5 and 10 minutes. The activity of palmitoyl-CoA synthetase 
is expressed as nmol paliiitoyl-CoA synthesized/brain per minute, in 
(a) the full homogenate (b) the membrane fraction (Fl) (c) -11-he 
mitochondria-enriched fraction (F 2) and (d) the microsomal fraction 
F3' All values are expressed as outlined for Figure 3.13. Control 
thyroxine ý, Io-o) PTUa and PTUb 
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3.4 THE INCORPORATION OF SODIUM f3H] PALMITATE INTO THE LIPIDS OF 
BRAIN SUBCELLULAR FRACTIONS FOLLOWING INTRACRANIAL INJECTION. 
The incorporation of [ 
3H]-labelled 
palmitate into brain tissue wins 
investigated in order to determine the inter-relationship betý-,, een 
the various subcellular fractions and the role of fatty acids in 
complex lipid metabolism. The study was carried out over two 
different time periods; 10 day old rabbits were sacrificed. Within 
one hour of intracranial injection-and 25 day old rabbits were 
sacrificed aithin 24 hours. These Wo time periods were chosen to 
measure the initial uptake of fatty acid moeities and their subsequent 
incorporation into conplex phospholipids. 10 day old rabbits have 
just reached the period of maximum myelin formation. -whereas at 25 
days the rate of myelination is declining (4). Animals were 
sacrificed by cervical dislocation and the brains were fractionated, 
as outlined in section 2.2.1. 
3 . 4.1. The Incorporation of [3 
HI palmitate into the lipids of sub1cellular 
fractions of rabbit brain: 
Although the radioactive fatty acid was injected intracranially, the 
recovery of radioactive material was low. Direct solubilisation of the 
crude homogenate. or extraction of lipid material prior to coun-ting 
gave the same results. The mean %/7 recovery of radioactivity from 
solubilised tissue was 10.2 
ý 3.1% for the 20 animals used in this 
study. 
Immediately following intracranial injection, 80% of the radioactivity 
recovered from the brain of 10 day old rabbits was found in the F1 
fraction. This fell to 70% within one hour (Table 3.9). 
The radioactivity recovered from the mitochondria-enriched fraction F2 
rose slightly from 15% to 23% during the same period. Less than 15% 
of the recovered radioactivity was found in the microsomal (F 3) and 
soluble (F 4) fra ctions. 
Incorporation of radioactivity into fractions Fl, F3 and F4 from 25 
day old rabbits was similar over 24 hours to that seen during the 
first hour following injection, in 10 day old rabbits (Table 3.9). 
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TABLE 3.9 
'4H palinitate into lipid extracted from subfractions Incorporation of I 
of young rabbit brain.. 
All values are expressed as % total amount of radioactivity recovered. 
Gradient subfractions are expressed as % total radioactivity in the 
original fraction. Experiment I was carried out over 60 minutes 
using 10 days old rabbits and Experiment II over 24 hours using 25 day 
old rabbits. All determinations i,,, ere carried out on two animals in 
duplicate. 
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The ', o radioactivity recovered from --' L. he mitochondria-enriched 
fraction (F /a 2) however, decreased from 27" to 12Z during the period 
of study. It is apparent, that fractions F, and F2 play a major 
role in the incorporation of fatty acids into cerebral lipids. 
The Z radioactivity incorporated into the lipids oil gradient sub- 
fractions obtained from fraction Fl-and F2 varied greatly in both 
10 and 25 day old rabbits. In general, only gradient fractions 
from fraction F2 gave consistent results in both studies. Fraction 
F22 identified as myelin (section 3.2.3.5) at all times contained at, 
least 501"1 of the radioactivelY-labelled lipid; (Table 3.9 ) tile 
microsomal fra 
, 
ction F 21 contained a large proportion of the balance. - 
in the r-., fraction 
The radioaýtivity recovered in the lipids extracted Irom subfractions 
of F, was mainly in fractions Fl, and F14 of 10 day old rabbits, but 
was rbcovered in greatest quantities fr oi-ii fractions F, 3 of 25 day old 
rabbits. Fractions F ill F 13 and F 14 have been tentatively identified 
as microsomal, mitochondrial and possibly originating artefac-11-ually 
from myelin 
The presence of fraction F14 in subf)-actions of F, makes interpretation 
difficult, because it is present to varying degrees in each sample 
and appears to increase with the time of storage at -20 
0 C. Assuming 
that fractions F. 11 and F21 are mainly mi%lrosomal, F22, F12 and F 14 are 
myelin, F 13 and- F23 mitochondrial in origin ,i1. is possible to express 
the data given in Table 3.9 to give the percent incorporation of 
radioactivity into tile lipids of each of the above subcellular organelles 
with time. 
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Radioactivity lrorii microsomal material was taken as the sum of the 
ý. 4.2. 
radioactivity from fractions F III F,,., and F3. The incorporation 
of radioactivity with time into ol-ganelles from 10 and 25 day old 
brains, is shown in Figs - 3.20 a and 3.20 b. In both cases there is a 
rise in the myelin content, of radio-labelled lipid, but in the one hour 
study (Fig. 3.20 a) this increase is- balanced by a fal I in the Micro- 
somal radiolipid content; whereas over a 24 hour period the rise in 
myelin radioactivity is balanced by a fall in the mitochondrial radio- 
active lipid (Fig. 3.20b). The differences in the distribution o, 
radioactivity betaeen the organelles from the two groups of animals 
one hour after intracerebral injection may be a-Ltributed both to age 
and differences in the composition of the subcellular fractions prepared.. 
The low percent radioa. ctivity recovered from the soluble F4 fraction 
may be due to the presence of soluble lipid-carrier proteins. 
3 The Incorporation of [ HI palmitate into the Oospholipid fraction 
of subcellular fractions of rabbit brain: 
Scanning thin layer chromatograms for radiolabelled lipids following 
separation of samples in petroleum ether: diethylether : acetic acid 
(75 : 25 : 1), it was apparent that only t-io radiolabelled spots were 
present. These were identified using authentic standards as f. re6' 
fatty acid and phospholipid. 
In all fractions prepared the amount of label found in the phospholipid fraction was at least 25% of the total radioactivity recovered one hour after Jntracerebral injection and greater than 70% of the total after 24 hours ýtable 3.10) Since the amount of label found in the phospholipid fraction (expressed as a percentage of the total) was determined in subfractions of fractions Fl and F2 from 10 day old rabbits, it was possible to plot the changes in the percentage of the total radioactive lipid recovered as phospholipid in the various subcellular organelles (Fig. 3.21) 
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The incorporation of 
3H-palmitate into -'the lipids of su'Dcel. lular 
organelles of*developing rat brain. 
(a) Incorporation of label into SUbcellular organelles of 10 day old 
rabbit brain. Values plotted are % radioactivity recovered in each 
organelled against time in minutes. Ilye Iin 
Mi crosomes 0-0 mi tochondri a D-0 and 
soluble fraction )j4, tt . 
(b) Incorporation of label into the lipids of subcellular organelles. 
of 25 day old rabbits. Values are plotted as % radioact-lvi-. '. y 
recovered in each organelle against time in hours. Mly eI in 
microsomes 0-0 mitochondria and 
soluble fraction. The-experiments were carried Out using two 
animals at each time and all values are the mean of several determin- 
ations carried out on the lipid extracts. 
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TABLE 3.10 
Incorporation of 
3H-palmitate into phospholipid in subfractions 
from developing rabbit 
, 
brain. Values are expressed as the amount 
of radioactivity recovered from the phospholipid component of the 
total lipid extract expressed as a% of the total radioactivity 
recovered. Experiment I was carried out on 10 day old rabbits 
and time is expressed in minutes. Experiment 11 was carried out 
on 25 day old rabbits and time is expressed in hours. Subfractions 
have the same designation as outlined in sections 2.2.1 and 2.2.2. 
All values are the mean of several determinations carried out on 
the lipid extracts from two animals at each timie. 
r_3 
cn co 
<C 
C, - C) 
-i Ld 
LLI 
C: ) 
c 
C) 
C-) 
U. 
- 
ca 
Ln 
CL 
__j C) 
CD 
LLI 
C) 
C: ) 
(Y) C) 
0- 
LL1 cl:: 
-i 
C: ) 
co C-) 
;2;: = 
F-4 
-zi- Lo cn rý I CQ m (71 
:3 '-O L", ILO r-_ ko 
4-) 0 
l 
co I I Cn I cn 
C: 
(L) 
F: 
C) C\j (\j 
(1) Lo I co I I II rý I I I f-- r-_ 
LLJ F= 
. I- 1-ý flo Irt cri 
C") 1 1 0) 
Lo I 
Cý 
(31 ce) C) 
I co LO 
C) M LO co LO C) -; t 0) CTA CF) I 
r-% CY) CY) rý 
U) 
4-) 
4-3 =3 
s_- C) C) 0) <n LO CY) C31, C) LO C? CD I 
m OD CF) m C\j (Y) r-. 4zr C\j LO I 
C: ) C: ) m co cy) ko m (y) ko Lo 
x 
I 
m C\j cli Cl) r- C1.1 Cýj CY) 
LO C: ) C\i C) C) ýtl ýt (71 C: ) 
LO r-_ ko I 
Co LO 00 (Y) C) 
C) (71 CIA tr) t-D C\j C: ) C: ) cn LO 
Cý, I C\j CY) C\j 
m LO o') Kl- I 
0 
. r. r- 0i CY) C\i CY) 
4-3 r- C\j (M C%j 
u L-1 LL- LL- LL- LL- LL- LL- 
Cd 
S. - C\j m LL- Ll- LL- LL. 
FTNIP'. 
-1 91 
The incorporation of 3H-palmitate 
10 day old rabbit brain. 
Values are expressed as the amoun 
the phospholipidis as a percentage 
recovered in the lipid extract of 
the phospholipids of 
intlsubcellular organelles of 
t of radioactivity recovered from 
of the total radioactivit 
that subcellular organelle. All 
points represent the mean for tvio animals., 
Mye 1in mitochondria LD-F) mi crosomes . ()-0 . 
( F11 I+jr 22. 
) ( F, ItR, 3) ( i:.. + F, 
', 
+ F. 3 
) 
sainurj-- La -wil 
0 
os 0- 
ON 
s, allaule5jo 
. jpjnjja: )qns jo sp! dipL4dsoL4d ; L41 olui al'ej! wIted-He jo l-lo! jejodjoouj LZ CD-jnBlj 
09 01 oz 
The rise in radiolabelled phospholipid in the microsomes is 
interesting since it occurredwhile the total microsomal radioactive 
-ent was falling. As indicated in the crude fraction lipid con-It, 
data (Table 3.10 ) the '/J' radio-phospholipid content of mitochondria 
and myelin also increased. The radiolabelled phospholipids from 
membrane (FI), mitochondrial-enrichbd (F 2) microsomal (F 3) and soluble 
(F e4 4) fractions from the 24 hour study ,.,, er identified by radio thin 
layer chromatography (Fig. 3.22 a, b, c, & d) and expressed as '. 10 total 
phospholipid. 
. 
In fractions F, and F2 (Fig. 3.22a & b) which contain 
all the myelin and mitochondria, the predominant radiolabelled phospho- 
lipid is phosphatidy1choline, whereas tile microsomal (F3 ) and soluble 
(F4) fractions (Fig. 3.22c & d) contain predominantly phosphatidyl-. 
ethanolamine. The occurrpnceof a large proportion of phosphatidic 
acid, 10-15'ý', in fraction F,, F2 and F4 may indicate either a high 
level of turnover of labelled phospholipids or, as is more probable, 
a large degree of spontaneous breakdown of the more labile phospholipids. 
The incorporation of label into most phospholipids identified was 
detected in trace amounts in all fractions at diflerent time intervals 
following filtracerebral injection (Fig-. 3.22a, b, c, & d). Thus indicating 
that all phospholipid classes are involved in the uptake and further 
metabolism of fatty acids and to differing degrees in different 
organelles. The presence of labelled phlospholipids in the soluble 
4) prob ýb. ly indicates the presence of lipid carrier-proteins fraction (F 1 
in the brain cell cytoplasm. 
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FIGURE 3.22 
The incorporation of 
3H-palmitate into various species of phospholipid 
in, #ubce, Vular fractions oF 25 day old rabbit brain. Values are 
expressed as % total radioactivity recovered from the phospholipid 
fraction. E ------- 0 phosphatidylserine and phospatidylinositol 
D----D sphingomyelin - Ar- - phosphalkidy1choline 
phosphatidyletlianolari. ine phosphatidic acid 
0 ....... 0 cardi ol i pi n. 
(a) changes in the distribution of radiolabelled phospholil pids in the 
menDfrane fraction (F, ) 
(b) changes in the distribution of radiolabellcd phospholipids in the 
mitochondria-enriched fraction (F2) 
(c) changes in the distribution of radiolabelled phospholipids in the 
microsomal fraction (F3) 
tribution of radiolabelled phospholipids in the , d) changes in the dis'. 
soluble fraction (F4). 
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4. DISCUSSION 
14yelination is a period of brain development &-ling which cor. -, iplex 
structural and functional changes take place. The synthesis of 
lipid material for the n. yelin membrane must therefore be under 
strict control. It has been shown in other studies (1,2,15,153, 
190) that slight disturbances during this period can lead. to major 
changes in both structure and function although soi-,,, e of'these are 
reversible. 
4* It is important therefore, to consider the key role played by fatty 
acids in normal brain devel6pment and, in particular, changes in 
lipogenic enzyme activity during Welination. It is also necessary 
to determine the subcellular site or sites of fatty acid synthesis, 
activation, and incorporatiop into complex lipids, in order to under- 
stand the major routes of lipid biosynthesis and at which points mal- 
function may lead to quantitative and qualitative changes in myelin. 
4.1 The incorporation of fatty acids int. 0 riyelin lipids follovdng intEý- 
cerebral injection: 
Intracerebral injection of labelled precursors has been used to cir- 
CUMvent any blood-brain barrier effect which may inhibit the uptake 
of metabolites by. the brain (105), although Dhopeshwarkar shoaed 
cerebral uptake - of acetate and palmitate within 15 seconds of carotid 
injection in the adult rat (99) and Davison and. Dobbing (94) concluded, 
from their experiments, that the uptake of circulatory phosphate into 
the brain was faster than the incorporation of the phosphate into 
phospholipid. 
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In the present study, intracerebral injection was chosen as a 
means ol introducing labelled fattýv acid into the brain 
because: 
1) two separate groups of rabbits of different ages were used and 
intracerebral injection of labelled fatty acid overcame any age- 
dependeýnt changes in the selective uptake phenomena exhibited by 
brain -tissue, and 
2) since young animals were used, inLracerebral injection of sub. - 
strate avoided undertaking the technically more demanding technqiue 
of carotid'injection. 
It is apparent, that of the labelled lipid recovery from the brain, 
at least 95',. 2' of 'Uie material was located in the memibrane fractions 
e, ýen immiediately following intracerebral inject-ion ( Fig. 3.20a) and 
of the subcellular organelles prepared, only myelin shol.,,, ed an increase 
in the % label recovered. Since the results in Figs. 3.20a and b and 
Fig. 3.21 are expressed in terms of Z total radioactivi V and no 
chow SW 
measure of the actual amount of radioactiviV or the4specific activity 
of the seperate lipid classes was made; the time-dependent accumulation 
of the label originating from [3 H] palmitate in the Welin fraction 
represents either a net gain in labelled material or a slower rate 
of loss of radioactivity than in other subcellular particles. That 
the total % recovery of injected radioactivity remained fairly constarrIC. ' 
during the 24 hour study supports net aCCUr-. xulation of, radiollaWled 
lipid by the myelin-fraction during this period. 
The constant % recovery of labelled lipid from the soluble fraction 
over 24 hours and the mitochondria in the short-term study and micro- 
somes in the long-term study may be indicative of either a fixed pool 
of labelled material or a dynamic situation in which the radiolabelled 
fatty acid is undergoing enzymatic modification 
Aile being trans- 
located from one organelle to another. The changing composition 
of the F2 and F3 phospholipids (Figs. 3.22b & c) over 24 hours suggests 
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that there is a dynamic flux of phospholipid through. these fractions. 
In the soluble fraction, however, the appearance of only one major 
phospholipid (Fig. 3.22 d) could indicate either a tissue pool or the 
presence of specific carrier lipoproteins which are involved in the 
transfer of phosphatidylethanolamine from the microsomes to other 
subcellular organelles. 
Tile involve-ment of soluble phospholipid carrier proteins has been 
ably demonstrated in both brain ( 120,123 , 191 , 192 ) and liver (116-119x,. 
Exchange of phosphatidy1choline between mitochondria and microsomes has 
been sho,. -in in both liver (119,118) and brain (191) but no evidence of 
in vitro exchange has been demonstrated between microsomies and myelin 
(192). 
Brammer and Shaltawy (193) suggest that the observed lack of phosphat-- 
idlycholine exchange in rp. yelin is due -L-. o the high negative charge of 
ti dy I chol ine this group of phospholipids. The interaction of phosphat. 
with myelin proteins may also inhibit the exchange of this phospholipid 
since Braun and Radin (194) sho,,.,! ed that sulphatide phosphatidy1choline 
and phosphatidylinositol could. be bound to proteolipid protein by 
nonionic association and Palmer and Dawson (50 3 60) showed that triphos- 
phoinositides and phosphatidy1choline combine readily t,,, ith myelin basic 
protein. 
-ructure It is apparent that myelin is a very specialised membrane st 
and the properties of the individual lipid and protein sped? s give 
it its structural and functional properties. 
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Lipid compositional changes which take place during maturation 
may be the result of exchange with protein-carried phospholipids 
which could be present in the continuous circuits of cytoplasm 
which are present in both imature and mature Melin ( 7). 
That there i's no clear pattern of transfer of radioactivity 
bet-ioen each class of subcellular particle and myelin -indicates 
that the riethod'of myelin formation during early postnatal develop- 
ment may be much iiiore complex than envisaged by cytoplasmic phospho- 
lipid transfer and may firstly involve membrane extrusion and then 
modification by phospholipid exchange and protein replacement and 
addition. 
87 
4.2 
4.2.1 
Changes in Lipogenic enzyme activitLdurinLdevelopment: 
The investigation of age-dependlent changes in enzyrne activity is 
of paramount importance in the understanding of r myelin foriiiation 
and subsequent maintenance of its composition. The enzymes 
investigated in this study, fatty aci d synthetase and pal-mitoyl- 
CoA synthetase, obviously play a central role in the formation and 
activation of fatty acids for incorporation into the phospholipids 
of tile myelin membrane. Since a large am. ount of lipid is incorp- 
orated into the developing myelin membrane efuring a very short time 
period, during most active myelination, changes in the activity of 
lipogenic enzymes would be expected. 
Fatty acid synthetase: 
The changes in the activity of tile soluble fatty acid synthetase 
com. plex are very similar in both the developing rabbit and rat brain 
(Figs. 3.3 - 3.6)-Ho,. -iever, I; he timing of the peak activity varied 
depending upon hoa tile data was expressed. The peak specific 
activity (per mg protein) of the rabbit brain enzyme occurred at 
4 days of age and of the rat bra-in enzyme occurred at 5 days. Th -1 s 
is before tile period of most active myelination and may account for 
the appearance of lipid droplets in the glial --ells prior to Pkyelin 
formation. Hoaever, the same data expressed in terms of rqg DNA, 
whole brain or gm viet weight sho,.,,, ed peak enzymie activity at '12 days 
of age which is during the period of most active myelination. 
That rat brain fatty acid synthetase has peak activity during nyelin- 
ation is in direct conflict witth the results of Vollpe and Kishimoto 
(112). 
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From, their results rat brain fatty acid synthetase activity 
(per gm wat weight) shows ri-aximum activity during the neonatal 
period and there is a progressive fall to adult values. This 
is in contrast with the concept that P.,, ost active myelination is 
associated with raised enzyp. l. e activity. Ho%-iever, this difference 
clay be explained by the fact that their rats were of the Sprague- 
Dawley strain whereas the Sheffield University colony is I. -Jistar 
strain. 
Assuming that the brain weight of rats of both strains is comparable 
at all ages, then it is possible to express the results of Volpe 
and Kishimoto ( 112) in terms of fatty acid synthetase activity per 
brain (Fig-4.1 b). The brain weights shown in Fig-4.1 a were 
obtained from Uistar rats and were used in the conversion of activity 
/gm wet weight into activi ty/whole brain. 
11 The shape of the curve is essentially that seen in Fig-3.5b e'cePt 
that peak activity appears to be at 18 days oil age instead of 13 days 
and the values are consistently 4 fold higher. 
Results expressed in terms of %-., hole brain activities may, therefore, 
show changes in enzyme activity that are not apparent ohen the 
results are expressed per gm wet ý. teight of tissue. The use of 
am %-tet weight of tissue in expressing enzyme activity, introduces 
a further parameter into the calculations which, although negligible 
in the adult animal, is directly related to the change in brain 
weight with increasing age. 
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PTr, [IPP AI 
(a) 
Increase in the brain weight of the developing Uistar rat. 
All. values are the mean + S. E. M. of all normal animals used 
and are plotted as gm laet weight against age. 
(b) 
The activity of fatty acid synthetase in the developing rat brain. 
The data of Volpe and Kishimoto ( 1,12) is re expressed in terms of 
nmol malonyl-CoA incorporated per brain per minute using the 
tie i ghts sho,.,., n in Figure 4.1 (a) 
(c) 
The activity of acet. oacetyl-CoA thiolase in the developing rat 
brain. 
This figure is compled from the data of Buckley and Williamson (206) 
and re expressed in terms of nmol acetyl-CoA formed per brain 
per minute using the jqeights shavin in Figure 4.1 (a). 
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5.0 
4.0 
3.0 
2.0 
1.0 
0 
10 20 -, )o 40 adult 
AGE (d ay s) 
Up to 13 days ol age the rat brain i-,, eighs loss Lthan I. Ogm (Fig. 4.1a) 
whereas above this age the brain weighs more than i. Ogril and the rate 
of weight gain decreases. Volpe and Kishfi.,, ioto (112) slicn,,! ed that 
the activity of rat brain fatty acid synthetase from anirnals fed a 
fat-free diet from birth to 65 days of age was 40'/0' higher than the 
activity of the enzyme from the brain of rats fed a high-fat diet. 
This suggests that the uptake of circulatory fatty acids ri,, ay be 
involved in the regulation of intracellular fatty acid synthesis in 
the normal developing brain. 
The existence Of fatty acid synthetase activity in the microswnal. 
fraction of brain tissue has been discussed by several workers (152 
19 
(5,196). 
Ammonium sulphate precipitates fatty acid synthetase 
from suspensions of both microsom. es and soluble proteins bebaeen 
30% and 5OZ3 saturation (195) and the enzyme can also be Separat. -d 
from crude nicrosomal material by sucrose density gradient centri- 
fugation. The activity of the mem5rane-bound fatty acid synthesising 
system has been shown (196) to have a similar age-dependent activity 
profile as the soluble enzyme, indicating that the soluble enzyme 
could be trapped within mei-ribrane vesicles or physically associated 
with the membrane fraction. Therefore, it is possible for the 
fatty acid synthetase complex to be loosely attached to the micro- 
somal m,, P,,, brane and liberated into the soluble fraction by homogen- 
isation. 
In an elegant study, Volpe et al (197) investigated the turnover of 
fatty acid synthetase using antibodies. The liver enzym-- content 
varied depending upon the nutritional status of the animal, whcreas 
the brain enzym, e content did not change. 
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The changes in brain fatty acid synthetase activity (112) seen on 
4.2.2 
different diets Must, therefore, be due to changes in short-term 
control, possibly allosteric control by the cytoplasr. -iic concentration 
of fatty acids or fatty acyl-CcA. The amounts of liver and brain 
enzyme are controlled by the rates of synthesis and degradation of the 
enzyme. In the brain, the half-life of the enzyme increases from 
1.9 days in the young suckling rat to 6.4 days in the adult animal. 
The increase in brain activity during myelination may be due to an 
increase in the rate of enzyme synthesis since the rate of degradation 
is high, as measured by the half-life. Obviously, the -turnover of 
the enzyme in the adult brain is maintained by a much lo-aer rate of 
en, zyme -synthesis and a decrease in the rate of degradation. Vol pe 
and Vagelos (198) also'sho-vied that the activity of brain fatty acid 
synthetase was not altered by the turnover of the 4-phosphopantetheine 
prosthetic group, although this moeity has a far higher turnover rate 
than the whole enzyme. 
Pal mi toy l -Go-A-Synthet as e 
It is apparent from the results presented in section 3.2.3 that any 
discussion of the cellular role and activity of palmitoyl-CoA 
synthetase must, of necessity, include sorne comment on its location 
among tile subcellular fractions and the composition of those 1'ractions. 
Of the four fractions 1hat were prepared by differential centrifugation 
(section 2.2.1) only fraction 
- -, 
F4 contains the soluble proteins 
from the cell cytoplasm but may also contain some very loa density, 
small vesicles of unknown origin, which may be the cause of the 
paln, itoyl-CoA synthetase activity in this fraction (table 3.5 ). 
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Fraction F3 was designated the microsomal fraction. The composition 
of fractions F1 and F2 was shcwn by rate zonal centrifugation (Fig. 3.11) 
to be similar in the number of constituent bands but differing in the 
amounts of them. The three major bands appear to be microsomes, 
Welin and mitochondria (section 3.3.2.5). Thus, if enzyme activil ty 
is detected in either of these fractions (Fl and F2) its subcellular 
location must be ascertained. 
The subcell. ular, location of brain acyl-CoA synthetase was shown by 
Pande and Mlead (149) to be microsomal and mi, tochondrial. Since they 
used a tissue fractionation procedure essentially the same as the one 
used in this study, the only fractions assayed for changes in palr., iitoyl. - 
CoA synthetase activity in the developing rabbit brain (section 3.2.3.4) 
were the crude homogenate, the niitochone-ria-enriched fraction F2 and 
the microsomal fraction F 3' lioaever, it wsas apparent from the large 
discrepancy betaeen the crude homogenate activity. and that recovered 
from the fractions (Table3.6)that a large proportion of the enzyne 
activity was lost during fractionation. Measurement Of palmitoyl- 
CoA synthetase in all the subcellular fractions prepared from adult 
rat brain showed%96% recovery (table 3.5 ). Hu. -iever the 'crude' F, 
fraction contained 80% of the enzy,, Pe activity. 
The discrepency between the activity in the homogenate and that 
recovered in the mitochondrial and microsomal fraction %-,, as also noted 
by Pande and I-lead (149) who suggested a plasma n. ambrane-locat-ion 'For 
palmitoyl-CoA synthetase. Washing the 'crude' F, fraction and osmotir 
shock of the resultant F, fraction liberated large quantities of 
palmitoyl-CoA synthetase (Table 3.5) but-a small residuai 
amount of activity remained in the myelin bond which Could not be 
removed by further density gradient centrift(Oation of that fraction. 
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This residual activity may be associated %-., ith a meri-brane fraction 
which has a similar buoyant densilcyto myelin, since purified myellin 
contains only limited enzymatic activity (52,54,199-201). 
Both heart and skeletal muscle contain a species of palmitoyl-CoA syn- 
thetase which is sedimented in the Yow nuclear fraction (148). This 
enzyme could be involved in the acylation of fatty acids diffusing 
through the plasma membrane in order to inhibit their leaving the 
cel I The presence of such an enzyme In brain tissue could play 
an important role in the control of uptake of circulatory fatty acids. 
Th 
(e 
role of palmitoyl-CoA synthetase in the microsomal fraction is 
o5viously to convert fatty acids synthesised in the cytoplasm into 
CoA-derivatives for incorporation into phospholipids since this is 
the site of phospholipid synthesis and ý-nax enzyme activity occ'urs during 
myelination. The low level of fatty acid activation in the miito- 
chondri'al-enriched fraction (F 2) seen when the results were expressed 
per mg protein (Fia-. 3.9b)is in agreement %., lith the theory, that brain 
tissue mainly uses glucose as a source of energy and so, although 
capable of carrying out o-o. -lidation (134), this is not a major routo 
of energy production in brain nitochondria. In contrast, the 
maximum whole brain activity of the enzyme in this fraction occurred 
'during myelination. These results could be explained if fatty acids 
were being activated for elongation by the mitochondrial system prior 
to incorporation into newly synthesised membranes. 
Much attention has been focussed on the microsornal fatty acid eionga- 
tion system. BaL imann et al (150-15ý) have identified two separate 
malonyl-CoA dependant elongation systems by ammonium sulphate 
the precipitation. This method relies on the protein content 0L 
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membranes comprising the microsomal fraction, whereas in the 
separation of palmitoyl-CoA synthetase activity in the microsomal 
.C fraction (F 14 3) by density gradient centrifugation (section 3.2.3.6), 
the inherent bouyant density of the membranes has been employed. 
Density gradient centrifugation has not been employed to differentiate 
between the elongation activity of heavy and light microsomal fractions 
or its spatial relationship with other lipogenic enzymes. The 
first peak, of palmitoyl-CoA synthetase activity (fraction 4-7 Fig. 3.12b) 
corresponds to a region of palmitoyl-CoA dependent incorporation of 
malonyl-CoA into long-chain fatty acids (195). The second region 
(fractions 11-13) of activity corresponds to an area of palmitwyl-CoA 
independent malonyl-CoA incorporation into long-chain fatty acids. 
Iý these membranes the size of the endogenous fatty acid pool may be 
sufficient for elongation. However, the two regions may have 
distinct roles in the metabolism of fatty acids. The first 
(fractions 4-7) may be involved in the activation of de novo and 
exogenous fatty acids while the second reglon may be involved -in the 
turnover ol endogenous fatty acids and de novo synthesis . 
I The administration of propylthiouracill (0.01ý, J %%, /v, in drinking viater) 
. -to pregnant rats, after day 13 Of gestation 
has been shown in other 
studies (202,203) to cause hypothyroid progeny. In the present 
study, pregnant rats %,,, ere given drinking water containing 0.02%ý 
propylthiouracil an d the pups showed classical signs of hypothyroid- 
ism. Their behavioural and morphological development was retarded 
by one or two days. Although test rat pups were maintained hypo-- 
thyroid by daily intraperitoneal injections of propylthiouracil, Clos 
et al (203) induced hypothyroidism in young rats solely by giving 
propylthiouracil to the mothers. 
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4- Since, in this study, no difference in brain and body weight f. Fig. 3.13 & 3.14) 
was detected between rats given propylthiouracil from birth (PTLIa) 
and those deriving the inhibitor from the mother (PTUb) it can be 
concluded that the level of thyroid hormone in the younq rat is 
either dependent upon the level of hormone in the maternal circulation 
and in the milk or that the potent inhibitor of thyroxine production, 
propylthiouracil, is secreted in the milk-and controls tile synthesis 
of thyroxine in the developing animal. 
In the normal rat, plasma thyroxine levels increase gradually fron. 
birth to a peak value at approximately 16 days of age ( 202 
and daily administration of propylthiouracil has been sho,,, jn to depress 
this maximum (202). Plasma iodine concentrations (Table 3.8 )sho,., i 
that there is a significant decrease in animals given propylthiouracil 
and thyroxine administration causes an increase. 11oi,., ever, the 
plasma iodine concentration is a function of the dietary intake o, 
iodine as well as the circulating levels of thyroxine. 
Vlysocki and Segal (202) showed that daily injections of I. Opg ttri- 
iodthyronine (T3) per gm body weight caused a 17% decrease in body 
weight and elevated the levels of UDP-galactose: sphingosine galactosyl- 
t ransferase and 2'3'nucleotide 3' phosphohydrolase in the rat spinal 
cord at 5 days. In the present study, there was also a 17% decr. -ase 
in body weight after five days of thyroxine administration (controi 
10.5gm, test 8.7gm) together with an 11% decree. se in brain weight. 
However, in-this study, no change in the activity of palmitoyl-CoA 
synthetase was detected. 
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The only detectable change in palmitoyl-CoA synthetase activity 
was recorded in the mitochondrial-enriched F2 fraction. In this 
fraction, the administration of propylthiouracil depressed the 
activity of the enzyme with respect to the control, whereas thyroxine 
had no effect. 
Balazs et al (155) suggested that the species of mitochondria in 
nerve terminals were selectively affected in the brains of hypo- 
thyroid animals. This conclusion was reached follo,. ý., ing studies of 
the enzyme content ol synaptosomal and free mitochondria. Although, 
in this study, no attempt was made to separate the Wo types of 
mitochondria, the suppression of palmitoyl-CoA synthetase activiV 
could be explained by a decrease in the number of synaptosomal mito- 
chondria. 
Extending this premise, the high levels of fatty acid activation 
detectable in the F2 fraction of the developing rabbit brain (Fig. 3.10) 
may be due to the presence of palmitoyl-CoA synthetase in synaptosomal 
mitochondria. This species of mitochondria may utilise fatty acids 
as an energy source during suckling, although glucose is the major 
energy source of the mature brain. 
Volpe and J, *ishir. ot. o (172) showed that thyroxine, hydrocort-isone and 
ady-enalectomy had no effect on rat brain fatty acid synthetase, but 
hypothyroidism caused a decrease in the activity of the enzym. e. The 
method of this control is unclear. Thus it appears that the hormonal 
control of brain fatty acid synthe'Lase is different to that in the 
Ii ver. 
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ýl 4.3 GDERAL DISCUSSIO. 
In the development of the central nervous system, tile period of 
maximum lipid accumulation correlates laith active myelinogenesis 
(4,27). Although there is considerable variation bet%-ieen m, arlmalian 
species as to the timing of the period of most active miyelination, 
in the rat, mouse and rabbit this occurs between 10 and 30 days 
after birth. Different regions of the brain cor-nence ,, ý. iyelin 
formation at different times, for example, myelin appears ir, the 
cerebellum. before the cerebral cortex (204). Therefore in -'Che 
developing brain there are temporal and anatomical differences in 
the deposition of cerebral lipids. The morphological differences 
probably reflect changes in the activity and control of those enzymes 
involved in myelin synthesis. 
The use of whole brain hor., ior-tenates, by definition, %.,, ill only yield 
'Aes of a results that are the mean of all the regional activit 
particular enzyme. However, more material is available for 
separation into subcellular fractions so that fei-: er animials are 
required and the biological variation is minimised. Data for many 
enzymes of lipid and energy metabolismhave been collated and are 
presented in Fig. 4.3 and Fig. 4.4 Before considering temporal 
changes in specific brain enzym, -_ activity it is ulorth considering 
the results of, experiments using brain sl. ices. 
Haximum synthesis of lipid frcn, acetate occurs bet-men 4 and 35 days 
in tissue slices (114 , 115 , 205 ). However, the synthesin. of 
lip-id 
f rom 91 ucose (115 , 205 ) appears to precede 
that f ro-in acetate by 
several days and follo,. Is the increase in brain 1 [pogenic enzyme 
activi-ty (205 ). 
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FIGURE 4.2 
Comparison o-l-' the activities of rabbit brain fatty acid synthetase 
and pallmitoyl-CoA synthetase laith the activities of other enz%,,, i"jes 
involved in fat'- acid synthesis and energy metabolism in the brain CY a 
at 20 days of age. The activity ol fatty acid synthetase (nuni,, ber 
8 in Figure 4.3 ) is shol, -in in terms of nrol rnalonyl-CoA incorporated 
per mig protein per ninute ) and also nrnol fatty acid 
synthesi zed per minu-'Ue per mig protein ( -- ). All data are 
converted to activity per n. g protein per minute and the width Of the 
bars represents the percentage homogenate protein. Three different 
ranges of activity are shuan 
Key to' enzyma, number and source. For Figures 4.2 and 4.3 
N 0. 1- nzyi-, qe Re f 
Acetyl-CoA carboxylase 113 
Acetil-CoA synthetase 213" 
3 Butyryl-CoA synthletase 213 
4 -ase Propionyl--CoA synthat 213 
5 Acet,,, 11-CoA synthet-ase 208 
6 Acetoace. -, yl-CoA'synt'., Iietase 
7 Acetoacetyl-CoA thiolase 208 
8 Fatty acid synthetase (rabbit') 214 
9 Fatty acid synthetase (MOLISe) 163 
10 Fatty acid synthetase (rat) 112 
11 Ilicroso-mal fatty acid synthesis (Le novo) 196 
12 Acyl-CoA synthetase 214 
13 Fatty acid desaturase 209. 
14 Fatty acid desaturase 215 
15 Fatty acid desaturase 216 
16 Synthesis of long-chain fatty alcohols 217 
17 Acyl-CoA hydrolase 211 
. 18 Acyl-CoA elongation (C 18-C20) 
163 
19 Acyl-CoA elongation ( 11 r'2 , _* ) 
218 
20- Acyl-CoA clongat-ion (lignoceric acid) 2918 
FIGURE 4.2 (Contd) 
110. Enzyme, Ref. 
21 Acyl-CoA elongation (C 16 -CIP ) 163 
22 I A Acyl-CoA elongation (rat nicrosormes) 196 
23 Hydroxylation of acyl groups 219 
24 Squalene 2 (3) epoxide lanosterol cyclase 218 
25 7 dehydrocholesterol reductase 220 
26 Plasi-. itialogen synthesis 210 
27 UDP galactose : Diglyceride galact -osyl transferase 221 
26 UDP galactose : HFA ceramide trans -, ',: 'erase 221 
29 UDP galaýtose : NFA ceramide transferase 221 
30 Monogalactose diglyceride synthesis 222 
31 Digalactose diglyceride synthesis 222 
32 Sulphatide synthesis 223 
33 Ceramide synthesis 211 
34 Acylation of glycerol-3-phosphate 228 
35 Glucose-6-phosphate dehydrogenase 224 
36 Lactate dehydrogenase 224 
37 Isocitrate dehydrogenase 225' 
38 Glycerol-3-phosphate dehydrogenase 226' 
39 Hexofinase 227', 
40 Aldolase 227 
41 ATP citrate lyase 208' 
42 Pyruvate dehydrogenase 206 
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FIGURE 4.3 
Peak activity of lipogenic and energy producing enzymes shown 
in days. 
Enzymes are identified as in the key for Figure 4.2 and the 
time scale -is in 5 day intervals from. birth. All values are 
taken directly from the original data and no account is taken 
of the original, mode of expression in compositing this ligure. 
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Although the amount of acetyl-CoA formed from glucose may rise 
from birth to 20 days of age as a result of the increased activity 
of pyruvate dehydrogenase (206), Carey (115) showed that tile amount 
of glucose converted to lipid in rabbit brain cortical slices 
decreased with age as the amount of glucose oxidised to CO 2 increased. 
Also, Patel and Owen (207) showed that maximum incorporation of 
ketone bodies into rat brain slices occurred 7 days after birth and 
the rate of lipid formation from this source was equal to. the waxim. um 
rates of the constituent component enzymes as measured by Buckley and 
Williamson (208). It is apparent that the rate of ketone body 
metabolism in brain slices is the same as the rates of enzyme acLivity 
measured in tissue homogenates and subcellular fractions. 
In F-19.4.3 the activities of rabbit brain fatty acid synthetase and 
palmitoyl-CoA synthetase are compared with the activities of Various 
brain enzymes involved in lipogenesis. Values are expressed in 
terms of nmol/mg protein per minute at 20 days of age. Since, in 
the original papers, enzyme activity was expressed in several different 
ways, the conversion to activity per mg protein per minute obviously 
involved the application of correction factors. It vias assumed, 
in the calculations, that the protein content of the different sub- 
cellular fractions aas the same as determined in the present studýv. 
Furthermore, in compiling Figs. 4.2 and - 4.3 ! the various enzymes 
were grouped according to their functions. Enzymes 1-7 are involved 
in the gP-ne), ation of precursors for -fatty acid synthesis. Enzymes 
8-23 are involved in the synthesis, activation and further illodi fi cation 
o, latty acids. Enzyr. n. es 24-34 are involved in cholesterol and- 
phospholipid synthesis and enzymes 35-42 are involved in energy 
metabolism and tile production of reduced NADIP for lipid s. ynthesis. 
98 
It is apparent that the cytoplasmic enzymes involved in glucose 
oxidation and NADPH t, 2 production have the highest activities and 
therefore, the generation of energy is not a rate limiting factor 
in the synthesis of cerebral lipids. The enzymes involved in the 
generation of precursors for fatty acid synthesis (No's 1-7 Fig. 4.2 
also have high activities indicating that fatty acid synthesis may be 
regulated by acetývl-CoA carboxylase or fatty acid synthetase and not 
by the availability of suitable precursors. In the present study, 
the activiýies of rat and rabbit brain fatty acid synthetase are 
very similar at 20 days (0.75nmol/mg protein/, min) and are considerably 
l. ower than those measured by Volpe and Kishiri-ioto (112)(4.1 nrniol/pig 
protein/min). Furthermore, the values available for the activity 
of acetyl-CoA carboxylase at this time are in the region of' 2.1nmol/wg 
protein/min (113,205); thus, acetyl-CoA carboxylase may not be the 
rate limiting enzyme of fatt acid synthesis since the difference in jy4 
activity between the tt, io enzymes is small. The microsomal enzymes, 
palmitoyl-CoA synthetase, fatty acid desaturase- (209), glycerol-3- 
phosphate acyl transferase (210) sphingosine acyl transferase (211 ) 
and 6f plasmalogen synthesis (21fl all have higher levels of enzyme 
activity than rabbit brain fatty acid syn"Chetase. The other 
enzymes qpted in Fig. 4.2 all have lower activies than fatty 
acid synthetase and are involved in complex lipid formation. There- 
fore, the activity fatty acid synthetase must regulate , the 
f *1 ow 
of de novo synthes ized fatty acids into the brain pool where thcy are 
modified and then. incorporated into phospholipids. Furthermore, 
the total activity of endogenous palmitate synthesis is 100 timnes 
greater than that of the microsomal elongation system.. In terms 
of acyl group formation and activation, the specific activity of the 
icrosomal palmitoyl-CoA synthetase is 50 tirres higher than that of mr 
fatty acid synthetase. 
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Taking into account the relative distribution of protein between 
fractions F3 and F41 the whole brain activity of microsomal palmitoyl- 
CoA synthetase is eight tiq,, -. s that of fatty acid synthelt-lase. Since 
palniitoyl-CoA synthetase is also present in the mitochondria-enriched 
fraction (F 2) and membrane fraction (Fl) and only 15' of the whole 
brain activity is found in the microsomal fraction (Table 3.5 ) then 
there is at least a 50 fold excess of palmitoyl-CoA synthetase 
activity over that of fatty acid synthetase. 
In the rabbit brain, tile incorporation of. fatty acids into cerebral 
lipids in vivo during the period of maximum lipid deposition is 
approximately 10mg/day (24). This value is at least three times 
hi 
( 
gher than the amount of fatty acid that can be synthesised by fatty 
acid synthetase per 24 hours in the whole brain. It is-obvious, 
therefore, that the developing brain is dependent. upon exogenous 
fatty acid during the period of maximum myelination and palmitoyl-CoA 
synthetase is necessary to activate any fatty acid taken up froni the 
circulation. Since it has been suggested that acyl-CoA synthetase 
may also have a plasma membrane location (149) it would be ideally 
situated to be intimately involved in the activation of extracerebral 
fatty acids and would stop a two-way diffusion of fatty acids across 
the plasma membrane by forming the CoA-derivative. 
Fi g. 4.3 shows di agram, mati cal ly the day at whi ch the enzymes cons i dered 
in Fig. 4.2 show peak activity. 
peak activity between-10 and 25 days. 
The riiajorit.,, ý, of tile enzymes slio,., i 
Since no attempt was made to 
standardise the methods o'f 'data expression, it is possible that some o-If 
the enzymes would show peak activity at other tirnes.. 
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However, the effect of expressing the results 
of Volpe and Kishimoto (112) for rat brain fatty acid synthetase 
in terms of whole brain activity instead of gm %-., et weight was to move 
peak acti vi ty f rcm birth to 13 days of age. Similarly, the results 
of Buckley and 1-1illiamson (209) lor acetoacetyi-CoA thiolase (No. 7 
Fig. 4.2 ) when expressed in terms of whole brain activity (Fig. Mc 
also show peak activity at 18 days of age. Thus, it is possible 
that if maximum whole brain ac-ILAvity were plotted against age then 
the number-of enzymes shoaing peak activity during the period ol 
most active wyelination, between 10 and 25 days after birth, would be 
even greater. 
The relationship of the enzymes involved in the catabolism of phos- 
pholipids is not well understood but they may be specifically involvee 
in the maintainence of the comiposition of membrane lipids and the 
regulation of metabolic pools which must exist in brain tissue. 
The role of palmitoyll-CoA synthetase in the i-ilitochondria-enriched 
fraction is not clear since.. although brain mitochondria are capable 
of oxidising fatty acid, the measured RQ for brain tissues is almost 
I indicating carbohydrate rather than lipid as the major energy source. 
Ho-aever, acetyl-CoA depend'-znt fatty acid elongation takes place in this 
fraction and palmitoyl-CoA synthetase could be involved in the 
activation of fatty acids prior (to elongation by this system. 
The synthesis and turnover of myelin lipids is a very complex procelss; 
ho, dever, the increase in activity of fatty acid synthetase and 
palnlitoyl-CoA synthetase in the rat and rabbit brain, together with 
other lipogenic enzyr, -, es during nýyelination (Fig. 4.3, indicate 
that this process is under very strict control. 
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Hormones uould be the obvious controlling factors, and especially' 
thyroid hormones since the highest concentrations ol thyroxine are 
found during the period of most active myelination. However, the 
administration of thyroxine does not increase the activity of fatty 
acid synthetase (112) or palnitoyl-CoA synthetase in the developing 
rat brain. Therefore, the role of this hormone in the control of 
fatty ac A synthesis and activation of fatty acids, may not be direct 
but may be involved in the rates of turnover of these enzyrne - 
systems and- thus control their activity by controlling the amounts 
present in the cell. The incorporation of labelled fatty acid into 
subcellular particles also does not appear simple since all fractions 
become labelled and only myelin lipids appeared to accumulate label. 
Ho-wever, several different membrane particles may be involved in 
the formation of a single phospholipid molecule and the transfer of 
a labelled moeity by cytoplasmic carrier-molecules could be responsible 
for the general labelling of subcellular fractions resulting in no 
obvious time course of incorporation. 
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